---

MTA IN PEDIATRIC DENTISTRY - Comprehensive Theory Examination Notes

---

PART 1: FROM THE UPLOADED BOOKS

---

1. INTRODUCTION AND HISTORICAL BACKGROUND

• MTA was developed by Dr. Mahmoud Torabinejad at Loma Linda University in the early 1990s, with the doctoral work supervised by Professor Thomas Pitt Ford.
• Its origins trace to civil engineering and the construction industry - it is fundamentally a hydraulic calcium silicate cement derived from Portland cement.
• Commercial introduction of ProRoot MTA began in 1998 by Tulsa Dental Specialties (Dentsply International) after FDA approval.
• MTA was designed to address the need for a repair material with ideal characteristics: biocompatibility, superior sealing ability, and ability to set in the presence of moisture.
• Over 1,000 publications exist regarding its properties and clinical efficacy, making it one of the most investigated dental materials. (Torabinejad Book, Preface)

---

2. COMPOSITION

2.1 Chemical Composition

• Primary components: Tricalcium silicate (Ca₃SiO₅), Dicalcium silicate (Ca₂SiO₄), Tricalcium aluminate (Ca₃Al₂O₆), Tetracalcium aluminoferrite (Ca₄Al₂Fe₂O₁₀)
• Radiopacifier: Bismuth oxide (Bi₂O₃) - approximately 20% by weight (distinguishes MTA from plain Portland cement)
• Small amounts of: silicon dioxide, calcium sulfate dihydrate (gypsum)
• Gray MTA (GMTA): Contains iron-containing tetracalcium aluminoferrite - responsible for gray color
• White MTA (WMTA - ProRoot): Reduced iron content, lower amount of aluminoferrite phase - designed to prevent tooth discoloration

2.2 Hydration Chemistry

• Primary hydration reactions:
  • 2Ca₃SiO₅ + 7H₂O → 3CaO·2SiO₂·4H₂O + 3Ca(OH)₂
  • 2Ca₂SiO₄ + 5H₂O → 3CaO·2SiO₂·4H₂O + Ca(OH)₂
• Products: Calcium silicate hydrate (CSH gel) (provides strength) + Calcium hydroxide (responsible for bioactivity and antimicrobial effect)
• Bioactive mechanism: Released Ca(OH)₂ reacts with tissue phosphate ions → hydroxyapatite precipitation → explains hermetic sealing and hard tissue formation (Sarkar et al. 2005, cited in Torabinejad Book, Ch. 2-3)

---

3. PHYSICAL AND CHEMICAL PROPERTIES

• Requires moisture for setting: Unlike most dental materials, MTA must be kept moist during setting; desiccation reduces strength and may cause incomplete hydration. (Torabinejad Book, Ch. 3; Camilleri Book, Ch. 1)
• Effect of EDTA on MTA: EDTA and BioPure MTAD have the greatest detrimental effect - EDTA chelates released calcium, disrupts calcium silicate hydrate formation, reduces microhardness and flexural strength. These irrigants should be flushed with distilled water before MTA placement. (Torabinejad Book, Ch. 3)
• pH effect: Microhardness significantly higher at pH 7.4 versus pH 4.4; acidic environments reduce setting quality.

---

4. BIOCOMPATIBILITY AND MECHANISM OF ACTION

4.1 Bioactivity (Physicochemical Basis)

• MTA is bioactive - when in contact with tissue fluid (phosphate-containing), it precipitates hydroxyapatite-like crystals on its surface and at the MTA-dentin interface.
• Sarkar et al. (2005) first described the interfacial layer between MTA and surrounding dentin - these globular precipitates are similar to hydroxyapatite, explaining the hermetic biological seal.
• The calcium released from MTA may interact with phosphorus in tissue fluid → hydroxylapatite formation → basis for successful clinical applications. (Torabinejad Book, Ch. 3)
• High calcium concentrations promote cell differentiation and hard tissue formation.

4.2 Biological Properties

• Biocompatible: Comparable cytotoxicity to calcium hydroxide in cell culture studies; freshly mixed MTA is more cytotoxic than set MTA.
• Antibacterial effect: Strong alkalinity (pH ~12.5) is responsible for antimicrobial activity; however, effect is less sustained than calcium hydroxide.
• Osteogenic potential: Upregulates osteoblast activity, promotes bone-like tissue deposition; supports cementoblast, odontoblast-like cell differentiation.
• Hard tissue formation: Induces formation of reparative dentin bridge (more homogeneous and continuous with original dentin vs. calcium hydroxide) and cementum-like tissue at periapical level.

---

5. CLINICAL APPLICATIONS IN PEDIATRIC DENTISTRY

5.1 INDIRECT PULP CAPPING

• Indicated when: thin layer of carious dentin remains over the pulp; no evidence of irreversible pulpitis or periapical disease.
• MTA may be used as a base after caries removal; alkaline pH limits bacterial growth.
• Evidence limited compared to direct techniques; calcium hydroxide remains commonly used for indirect capping.

---

5.2 DIRECT PULP CAPPING (DPC)

Indications

• Mechanical (iatrogenic) or traumatic exposure of vital pulp
• Carious exposure in a cooperative patient with no symptoms of irreversible pulpitis
• More conservative than pulpotomy - preserves maximum coronal pulp tissue

Clinical Steps

1. Local anesthesia, rubber dam isolation
2. Caries removal under high-speed with water coolant (avoid desiccation)
3. Hemorrhage control with sterile saline-moistened cotton pellets
4. Assessment: if bleeding controlled in <5 minutes, DPC is appropriate
5. Mix MTA to a putty-like consistency; apply 1.5-3.0 mm thickness over exposure site
6. Cover with glass ionomer or flowable composite; light cure if required
7. Restore with adhesive/final restoration at same appointment (WMTA)
8. Review at 3, 6, 12 months

Advantages of MTA over Calcium Hydroxide for DPC

• More consistent dentin bridge formation - bridges are thicker, more homogeneous, tunnel-defect free
• MTA bridges contain fewer tunnel defects (pathways for bacterial microleakage)
• Less internal resorption compared to calcium hydroxide
• Superior long-term pulp vitality rates
• No resorption of the material; calcium hydroxide gradually dissolves and leaves voids
• Bioactive - actively promotes hard tissue formation rather than simple alkaline effect
• Calcium hydroxide bridges often demonstrate tunnel defects and internal resorption; MTA produces superior histological results (Torabinejad Book, Ch. 4)

Limitations of DPC in Primary Teeth

• Primary teeth have abundant accessory canals in furcation area
• High risk of inflammatory resorption; DPC generally not recommended for primary teeth with carious exposures (AAPD position)
• Reserved primarily for mechanical exposures in primary teeth; MTA DPC of primary teeth remains debated

---

5.3 PULPOTOMY

5.3.1 Pulpotomy in PRIMARY TEETH

Background

• Formocresol pulpotomy was the gold standard for decades; however, concerns about formaldehyde toxicity, mutagenicity, tissue fixation, and internal root resorption led to search for alternatives.
• MTA emerged as a superior, biocompatible alternative to formocresol and ferric sulfate.

Indications

• Vital primary molar with carious pulp exposure
• No evidence of irreversible pulpitis or radicular involvement (no furcation radiolucency, no pathological root resorption, no pain on palpation/percussion, no sinus tract)
• Restorable tooth with adequate remaining structure

Clinical Procedure - MTA Pulpotomy in Primary Teeth

1. Local anesthesia; rubber dam isolation
2. Complete caries removal; access cavity preparation with high-speed
3. Coronal pulp amputation using large round bur or sharp spoon excavator - remove entire coronal pulp
4. Irrigate with sterile saline; hemostasis with moistened cotton pellet (pressure ~5 min)
5. Assess pulp stumps: Bleeding should be controllable and bright red (not dark, indicating inflammation)
6. Mix MTA to a putty consistency; place over pulp stumps, adapt with moist cotton pellet
7. Thickness of MTA: minimum 2-3 mm
8. Place a moist cotton pellet over MTA; close temporarily (resin/IRM/GIC)
9. At second appointment (24-48 hours): remove cotton, check MTA setting, restore with GIC base + stainless steel crown (SSC) or composite
10. Stainless steel crown is the restoration of choice to protect against microleakage and tooth fracture

Why MTA Produces Superior Results in Primary Molar Pulpotomy

• Formation of dentin bridge/hard tissue barrier at amputation site - calcium hydroxide and formocresol do NOT induce this in primary teeth
• No formaldehyde - eliminates toxicity concerns
• Less internal root resorption - maintains root architecture until physiological exfoliation
• Maintains furcation integrity - better radiographic outcomes
• Promotes healing through bioactive mineralization (Torabinejad Book, Ch. 4)

Radiographic Outcomes (MTA Pulpotomy - Primary Teeth)

• Success rate: 92-97% clinically and radiographically at 24 months (Torabinejad Book, Ch. 4; Doyle et al. 2010)
• Significantly lower incidence of internal root resorption, furcation radiolucency, and periapical pathology compared to formocresol

5.3.2 Pulpotomy in IMMATURE PERMANENT TEETH (Partial/Complete)

Partial Pulpotomy (Cvek Pulpotomy)

• Definition (AAPD): Removal of pulpal tissue beneath the exposure to a depth of 1-3 mm to reach healthy tissue (Torabinejad Book, Ch. 4)
• Indications: Carious or traumatic pulp exposure in immature permanent tooth with vital pulp; no signs of irreversible pulpitis
• Goal: Preserve apical radicular pulp → allow continued apexogenesis (root maturation)

Full Coronal Pulpotomy

• Indicated when partial pulpotomy fails or entire coronal pulp is inflamed
• Preserves radicular pulp; allows apexogenesis

Clinical Steps for Partial Pulpotomy (MTA)

1. Anesthesia, rubber dam
2. Remove only the inflamed pulpal tissue - extend approximately 2 mm into pulp
3. Use round diamond bur at high speed with water cooling (avoid spoon excavators - cause torsion/tearing of pulp tissue)
4. Wash with sterile water or physiologic saline; re-examine for clean amputation
5. Hemostasis: Cotton pellets dampened with sodium hypochlorite (SH); pressure for 30-60 seconds
6. If hemorrhage continues → amputation carried deeper
7. Avoid excessive air on exposed pulp (causes desiccation damage)
8. Once hemostasis achieved: apply MTA 1.5-3.0 mm in thickness
9. Cover with thin layer of flowable GIC or composite; light cure
10. Complete final restoration (Torabinejad Book, Ch. 4)

Results - MTA vs. Calcium Hydroxide for Partial Pulpotomy

• MTA consistently shows better dentin bridging - more homogeneous, continuous with original dentin
• Less pulpal inflammation in MTA-treated teeth in both canine and human in vivo studies
• Dentin deposition begins earlier with MTA (Abedi et al. 1996; Myers et al. 1996; Pitt-Ford et al. 1996, cited in Torabinejad Book)
• Success rates reported: 93-100% over 24-48 month follow-up

---

5.4 APEXIFICATION WITH MTA APICAL PLUG

Background

• Apexification is a method to induce apical closure in teeth with necrotic pulps and open, blunderbuss apices (immature permanent teeth).
• Traditional method: Calcium hydroxide (Ca(OH)₂) dressing changed every 3-24 months until barrier forms; major drawback: 2-4 years of treatment, patient compliance issues, risk of root fracture (weakens root dentin with long-term Ca(OH)₂ use).
• MTA apical plug technique: Creates an immediate hard-tissue barrier allowing single-visit (or two-visit) apexification.

MTA Apical Plug - Concept

• MTA is condensed into the apical 4-5 mm of the root canal creating an artificial apical stop/barrier
• The strongly alkaline, bioactive MTA:
  • Seals the apex against microleakage
  • Stimulates cementum/bone formation at periapex
  • Eliminates waiting time for biological barrier
• Remainder of canal obturated with gutta-percha or MTA full-canal fill (Camilleri Book, Ch. 6; Torabinejad Book, Ch. 5)

Indications

• Immature permanent tooth with necrotic pulp and open apex
• Failed apexogenesis due to pulp necrosis from trauma or deep caries
• Most common in maxillary central incisors - trauma during school age

Clinical Technique (MTA Apical Plug)

1. Access cavity preparation
2. Infection control - thorough chemo-mechanical debridement (canal enlargement limited by thin immature root walls; use gentle irrigation with dilute NaOCl)
3. Intracanal Ca(OH)₂ dressing for 1-4 weeks to control infection/reduce bacterial load (some protocols skip if tooth initially clean)
4. Second appointment:
   • Confirm canal is dry and free of exudate
   • Prepare apical end with large file sizes
   • Check working length with radiograph
5. Mix WMTA to putty consistency; carry into canal with MTA carrier or plugger
6. Compact MTA to apical 4-5 mm with paper points or dry cotton pellets
7. Verify apical plug position radiographically
8. Place moist cotton pellet and close temporarily
9. Allow MTA to set 24-48 hours
10. At subsequent appointment: verify MTA hardness with explorer; obturate remaining canal space with gutta-percha or composite resin buildup
11. Restore with adhesive post/composite if needed (Torabinejad Book, Ch. 5; Camilleri Book, Ch. 6)

Advantages of MTA Apical Plug over Ca(OH)₂ Apexification

• Significantly fewer visits (2-3 vs. multiple over years)
• No waiting for calcific barrier - immediate apical seal
• Better sealing ability - forms hermetic biological seal with hydroxyapatite precipitation
• Promotes periapical healing (bioactive, stimulates hard tissue)
• Predictable outcome without need for long-term monitoring
• Reduces risk of root fracture - canal can be filled and restored earlier
• Ca(OH)₂ treatment weakens root (hydrolysis of collagen) if used >1 month (Torabinejad Book, Ch. 5)

Outcomes - MTA Apical Plug

• High success rates: 70-95% in long-term studies
• Resolution of periapical pathology
• Barrier formation confirmed histologically (cementum/bone-like tissue)
• A key landmark study (Shabahang & Torabinejad, 2000) demonstrated successful apical closure with MTA in dog teeth (Torabinejad Book, Ch. 5)
• Linsuwanont (2003) noted that "with MTA, formation of the apical barrier is predictable and it is not necessary to monitor" (Torabinejad Book, Ch. 3)

---

5.5 ROOT PERFORATION REPAIR

Background

• Root perforations may result from: (a) access preparation errors, (b) excessive canal instrumentation, (c) internal/external root resorption (Torabinejad Book, Ch. 7)
• Furcal perforations in primary molars and immature permanent teeth are a specific pediatric concern
• Prior materials (amalgam, IRM, SuperEBA) lacked biocompatibility with furcal tissues

MTA for Perforation Repair in Pediatric Context

• Ford et al. (1995) - landmark study using MTA for repair of furcal perforations; demonstrated significantly better outcomes than amalgam (cited in Torabinejad Book, Ch. 7)
• MTA is the material of choice for furcal perforation repair due to:
  • Biocompatibility with furcal/periodontal tissues
  • Ability to set in the presence of blood/moisture
  • Stimulates periodontal ligament healing
  • Prevents communication between canal and periodontium
• Key factors for success: Size of perforation (smaller = better prognosis), time of repair (immediate = better), location (cervical = worse), degree of infection

Technique

1. Identify perforation site radiographically
2. Disinfect with NaOCl; hemostasis if needed
3. MTA mixed to a creamy/putty consistency; place directly into perforation
4. Compact gently without pushing material through perforation
5. Cover with moist cotton; seal temporarily; re-examine 24-48 h
6. Complete endodontic treatment and restore (Torabinejad Book, Ch. 7)

---

5.6 ROOT-END FILLING (PERIAPICAL SURGERY IN CHILDREN)

• Although less common in children, MTA is the material of choice for root-end fillings during apical surgery when conventional endodontic treatment has failed
• Superior to amalgam, IRM, and Super EBA in sealing ability and biocompatibility (Camilleri Book, Ch. 9)
• Evidence from Camilleri Book (Ch. 9): MTA vs. Super EBA - MTA 95.6% vs. Super EBA 93.1% at 12 months (Song & Kim); MTA vs. IRM - MTA 92% vs. IRM 86% (Lindeboom et al.)
• MTA root-end fillings produce significantly better radiographic success compared to no root-end preparation/filling; outcomes similar to IRM and Super EBA but with superior biocompatibility

---

5.7 REGENERATIVE ENDODONTICS (MTA AS CORONAL SEAL)

• MTA plays a critical role as the coronal plug in regenerative endodontic procedures (REPs/revascularization) for necrotic immature permanent teeth.
• After disinfection and blood clot/scaffold formation, MTA (3 mm) is placed over the blood clot as a cervical plug to maintain the regenerative environment
• White MTA preferred to avoid discoloration (Torabinejad Book, Ch. 6)

Protocol (Torabinejad Book, Ch. 6)

1. First appointment: Access, minimal instrumentation, 1.5% NaOCl irrigation, Ca(OH)₂ or triple antibiotic paste (TAP) intracanal medicament
2. Second appointment (2-4 weeks): Confirm absence of symptoms; remove medicament; re-irrigate gently
3. Create apical bleeding by overinstrumentation to apex; blood clot forms in canal
4. Place MTA (3 mm) over clot at CEJ level
5. Moist cotton pellet; seal with GIC + composite restoration
6. Follow up: root development continuation expected (increased length, wall thickness, apex closure)

• MTA's sealing ability and biocompatibility make it indispensable in regenerative protocols

---

5.8 MAINTENANCE OF PRIMARY TEETH WITHOUT PERMANENT SUCCESSORS

• MTA is used to completely fill the root canal system of primary teeth lacking permanent successors (congenital absence of premolars) to maintain arch space and alveolar bone
• After pulpectomy-type preparation, entire canal filled with MTA to avoid extrusion into periapical region
• Rationale: long-term maintenance of primary teeth as natural space maintainers (Camilleri Book, Ch. 6)

---

5.9 DENS INVAGINATUS

• Dens invaginatus is a developmental anomaly (classified by Oehler as Types I, II, III) commonly in maxillary lateral incisors
• May lead to pulp compromise and periapical lesion
• MTA apical plug technique applicable in these cases, especially where apex is open or aberrant
• Management includes prophylactic sealing, conventional endodontics, endodontic surgery, or combinations (Camilleri Book, Ch. 6)

---

6. DISCOLORATION - A KEY PEDIATRIC CONCERN

• Gray MTA (GMTA) caused significant tooth discoloration - clinically unacceptable in anterior esthetic zone
• White MTA (WMTA) was developed to overcome this; however, discoloration has still been reported with WMTA
• Mechanism: Bismuth oxide reacts with NaOCl → dark bismuth compounds; also oxidation products of iron
• In pediatric context: WMTA preferred for anterior teeth; for posterior (primary molars) where esthetics less critical, GMTA acceptable
• Alternative approach: Use Biodentine (no bismuth oxide, no discoloration) especially for anterior teeth in children (Camilleri Book, Ch. 8)

---

7. COMPARISON WITH OTHER CALCIUM SILICATE MATERIALS (RELEVANT TO PEDIATRIC USE)

---

8. DISADVANTAGES AND LIMITATIONS

1. Long setting time (2.5-4 hours) - requires second appointment for restoration
2. Tooth discoloration - especially with gray MTA and when in contact with NaOCl
3. Difficult manipulation - sandy, granular consistency; difficult to place in small spaces
4. High cost compared to calcium hydroxide and formocresol
5. Not easily retrievable once set
6. Solubility - slight solubility over time may create voids
7. Effect of contaminants - blood, irrigants (EDTA, CHX) may compromise setting
8. No antimicrobial substantivity compared to Ca(OH)₂ which releases OH⁻ ions slowly (Torabinejad Book, Ch. 4; Camilleri Book, Ch. 1)

---

9. CONTRAINDICATIONS AND PRECAUTIONS IN PEDIATRIC CONTEXT

• Not recommended in teeth with:
  • Irreversible pulpitis (except pulpotomy as indicated)
  • Severe periradicular infection not amenable to conservative treatment
  • Non-restorable teeth
• Isolation mandatory: Rubber dam essential; contamination with saliva compromises setting
• Avoid excessive air drying of pulp surface (desiccation damages remaining pulp tissue)
• Adequate hemostasis must be achieved before MTA placement (Torabinejad Book, Ch. 4)

---

---

PART 2: LANDMARK AND RECENT LITERATURE SUPPORT

---

A. LANDMARK STUDIES (Historical Foundation)

A.1 Development and Introduction of MTA

1. Torabinejad M, Watson TF, Pitt Ford TR (1993). Sealing ability of a mineral trioxide aggregate when used as a root end filling material. J Endod. 1993;19(12):591-5. [PMID: 7506137]
   • Significance: First publication introducing MTA as a root-end filling material; demonstrated superior sealing ability compared to amalgam in a dye leakage model; this is the founding paper of MTA in dentistry.
2. Torabinejad M, Hong CU, McDonald F, Pitt Ford TR (1995). Physical and chemical properties of a new root-end filling material. J Endod. 1995;21(7):349-53.
   • Significance: Characterized setting time, compressive strength, solubility, and established that MTA possessed superior properties to contemporary materials.
3. Ford TR, Torabinejad M, McKendry DJ, Hong CU, Kariyawasam SP (1995). Use of mineral trioxide aggregate for repair of furcal perforations. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1995;79(6):756-63.
   • Significance: Pioneering clinical study - directly relevant to pediatric dentistry - demonstrating MTA's superiority over amalgam for furcal perforation repair; established MTA as material of choice for this application.
4. Torabinejad M, Chivian N (1999). Clinical applications of mineral trioxide aggregate. J Endod. 1999;25(3):197-205.
   • Significance: First comprehensive clinical review of MTA applications - landmark paper codifying indications for pulp capping, pulpotomy, apexification, perforation repair, and root-end filling.
5. Pitt Ford TR, Torabinejad M, Abedi HR, et al. (1996). Using mineral trioxide aggregate as a pulp-capping material. J Am Dent Assoc. 1996;127(10):1491-4.
   • Significance: First clinical study on MTA pulp capping; established clinical protocol and early evidence of success.

---

A.2 MTA Pulpotomy in Primary Teeth - Landmark Evidence

1. Eidelman E, Holan G, Fuks AB (2001). Mineral trioxide aggregate vs. formocresol in pulpotomized primary molars: a preliminary report. Pediatr Dent. 2001;23(1):15-8. [PMID: 11242755]
   • Significance: First RCT comparing MTA with formocresol in primary molars; MTA showed 100% clinical and 97% radiographic success vs. 100% and 93% for formocresol; established MTA as viable alternative to formocresol.
2. Holan G, Eidelman E, Fuks AB (2005). Long-term evaluation of pulpotomy in primary molars with gray ProRoot MTA and formocresol. Pediatr Dent. 2005;27(2):128-32.
   • Significance: 56-month follow-up study; MTA pulpotomy success 92% vs. formocresol 76%; confirmed long-term superiority of MTA; demonstrated that MTA maintains furcation integrity and reduces internal root resorption.
3. Doyle TL, Casas MJ, Kenny DJ, Judd PL (2010). Mineral trioxide aggregate produces superior outcomes in vital primary molar pulpotomy. Pediatr Dent. 2010;32(1):41-7. [Cited in Torabinejad Book]
   • Significance: Prospective randomized study showing significantly better outcomes with MTA vs. formocresol; confirmed superiority in preventing internal resorption.

---

A.3 MTA Apexification - Landmark Evidence

1. Shabahang S, Torabinejad M (2000). Treatment of teeth with open apices using mineral trioxide aggregate. Pract Periodontics Aesthet Dent. 2000;12(3):315-20.
   • Significance: Demonstrated apical closure with MTA in animal model; established biological basis for MTA apical plug.
2. Shabahang S, Torabinejad M, Boyne PP, et al. (1999). A comparative study of root-end induction using osteogenic protein-1, calcium hydroxide, and mineral trioxide aggregate in dogs. J Endod. 1999;25(1):1-5.
   • Significance: Showed MTA produced superior apical closure compared to Ca(OH)₂ and osteogenic protein-1 in dog teeth with open apices.
3. Witherspoon DE, Ham K (2001). One-visit apexification: technique for inducing root-end barrier formation in apexification. J Endod. 2001;27(11):643-8.
   • Significance: Clinical report establishing single-visit MTA apical plug technique; contrasted with multi-visit Ca(OH)₂ approach; major advance in pediatric endodontics.

---

A.4 Biocompatibility and Mechanism - Landmark Basic Science

1. Sarkar NK, Caicedo R, Ritwik P, et al. (2005). Physicochemical basis of the biological properties of mineral trioxide aggregate. J Endod. 2005;31(2):97-100. [Cited in Torabinejad Book]
   • Significance: Defined the hydroxyapatite interface mechanism of MTA - the physicochemical basis for bioactivity, sealing ability, and tissue induction; one of the most cited MTA papers.
2. Torabinejad M, Hong CU, Pitt Ford TR, Kettering JD (1995). Cytotoxic effects of all preparations of mineral trioxide aggregate on cultured cells. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1995;80(6):700-8.
   • Significance: Established that set MTA is significantly less cytotoxic than freshly mixed MTA; demonstrated biocompatibility of the material; foundational safety data.

---

B. RECENT SYSTEMATIC REVIEWS AND META-ANALYSES (2017-2025)

B.1 Vital Pulp Therapy in Primary Teeth

1. Coll JA, Seale NS, Vargas K, et al. (2017). Primary tooth vital pulp therapy: A systematic review and meta-analysis. Pediatr Dent. 2017;39(1):16-123. [PMID: 28292337] [Evidence Tier 1 - Systematic Review + Meta-analysis]
   • Findings: Comprehensive meta-analysis of vital pulp therapy in primary teeth; MTA and ferric sulfate showed higher clinical and radiographic success rates than formocresol; MTA demonstrated success rates of 97% (clinical) and 94% (radiographic) at 24 months.
   • Clinical Implication: MTA is recommended as a superior alternative to formocresol; evidence supports MTA as first-line material for primary molar pulpotomy.
2. Smaïl-Faugeron V, Glenny AM, Courson F, et al. (2018). Pulp treatment for extensive decay in primary teeth. Cochrane Database Syst Rev. 2018 May 31;5:CD003220. [PMID: 29852056] [Evidence Tier 1 - Cochrane Systematic Review]
   • Findings: High-quality Cochrane review covering all pulp treatments; found MTA and ferric sulfate produced similar high success rates; very low certainty evidence limits definitive conclusions; formocresol remains in use despite biological concerns.
   • Limitation: Insufficient head-to-head RCT data to firmly rank materials.
3. Nagendrababu V, Pulikkotil SJ, Veettil SK, et al. (2019). Efficacy of Biodentine and mineral trioxide aggregate in primary molar pulpotomies - a systematic review and meta-analysis with trial sequential analysis of RCTs. J Evid Based Dent Pract. 2019;19(1):44-52. [PMID: 30926099] [Evidence Tier 1]
   • Findings: Both MTA and Biodentine showed similarly high clinical and radiographic success rates in primary molar pulpotomy; no statistically significant difference; Biodentine has the advantage of no discoloration and shorter setting time.
   • Clinical Implication: Biodentine is a clinically equivalent alternative to MTA in primary molar pulpotomy; choice may depend on esthetic considerations (anterior teeth = Biodentine preferred).
4. Coll JA, Dhar V, Chen CY, et al. (2023). Primary tooth vital pulp treatment interventions: Systematic review and meta-analyses. Pediatr Dent. 2023;45(6):326-386. [PMID: 38129755] [Evidence Tier 1]
   • Findings: Updated comprehensive meta-analysis (updating Coll 2017); MTA continues to demonstrate superiority in vital pulp therapy; network meta-analysis places MTA and calcium silicate cements at the top for overall success.
   • Clinical Implication: MTA/Biodentine represent current evidence-based best practice for primary molar pulpotomy.
5. Coll JA, Dhar V, Chen CY, et al. (2024). Use of vital pulp therapies in primary teeth 2024. Pediatr Dent. 2024;46(1). [PMID: 38449041] [Evidence Tier 1]
   • Findings: AAPD-supported updated guidelines; endorses MTA and Biodentine as first-line agents for primary molar pulpotomy; moves away from formocresol as gold standard.
   • Clinical Implication: Current AAPD guideline-level evidence supporting MTA pulpotomy in primary teeth.
6. Lu KY, Gibbs JL, Wu CY (2025). Efficacy of Biodentine versus mineral trioxide aggregate in pulpotomy for primary teeth: A systematic review and meta-analysis of RCTs. J Evid Based Dent Pract. 2025 Dec. [PMID: 41290279] [Evidence Tier 1 - Most Recent]
   • Findings: Most recent (2025) head-to-head comparison; no significant difference between Biodentine and MTA in clinical and radiographic success in primary molar pulpotomy; both show >90% success rates.
   • Clinical Implication: Both materials are evidence-based, guideline-supported options; material selection may be guided by cost, setting time, and esthetic requirements.

---

B.2 Vital Pulp Therapy in Immature/Mature Permanent Teeth

1. Brizuela C, Ormeño A, Cabrera C, et al. (2017). Direct pulp capping with calcium hydroxide, mineral trioxide aggregate, and Biodentine in permanent young teeth with caries: A randomized clinical trial. J Endod. 2017;43(11):1776-1780. [PMID: 28917577] [Evidence Tier 3 - RCT]
   • Findings: At 12-month follow-up, MTA (100% success) and Biodentine (93.3% success) significantly outperformed calcium hydroxide (66.7%) for direct pulp capping in young permanent teeth with carious exposures; MTA produced highest rates of dentin bridge formation.
   • Clinical Implication: Strong RCT evidence supporting replacement of Ca(OH)₂ with MTA or Biodentine for DPC in children's permanent teeth.
2. Ather A, Patel B, Gelfond JAL, et al. (2022). Outcome of pulpotomy in permanent teeth with irreversible pulpitis: a systematic review and meta-analysis. Sci Rep. 2022;12(1):19740. [PMID: 36385132] [Evidence Tier 1]
   • Findings: Overall success rate of pulpotomy in permanent teeth with irreversible pulpitis was 81.7%; MTA-based treatments showed high success rates; pulpotomy using bioceramics is a valid alternative to root canal treatment in suitable cases.
3. Fasoulas A, Keratiotis G, Spineli L, et al. (2023). Comparative efficacy of materials used in patients undergoing pulpotomy or direct pulp capping in carious teeth: A systematic review and meta-analysis. Clin Exp Dent Res. 2023;9(6):1170-1183. [PMID: 37710421] [Evidence Tier 1]
   • Findings: MTA and calcium silicate cements significantly outperform calcium hydroxide for both pulpotomy and direct pulp capping outcomes; NMA confirms MTA/calcium silicates at highest rank for success.

---

B.3 Apexification

1. Chala S, Abouqal R, Rida S (2011). Apexification of immature teeth with calcium hydroxide or mineral trioxide aggregate: Systematic review and meta-analysis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2011;112(4):e229-36. [PMID: 21778090] [Evidence Tier 1]
   • Findings: MTA apexification achieved significantly faster clinical resolution than Ca(OH)₂ apexification; treatment duration with MTA: 1-2 visits vs. months to years with Ca(OH)₂; no significant difference in final success rates; MTA avoids risks of prolonged Ca(OH)₂ treatment (root fracture, non-compliance).
   • Clinical Implication: MTA apical plug is the preferred method for apexification in children - fewer visits, predictable outcomes.
2. Lin JC, Lu JX, Zeng Q, et al. (2016). Comparison of MTA and calcium hydroxide for apexification of immature permanent teeth: A systematic review and meta-analysis. J Formos Med Assoc. 2016;115(7):523-30. [PMID: 26911724] [Evidence Tier 1]
   • Findings: MTA showed significantly higher overall success rate (93.5%) compared to Ca(OH)₂ (85.0%) for apexification; MTA significantly reduced treatment time; confirmed MTA as first-line treatment for apexification.
3. Kahler B, Rossi-Fedele G, Chugal N, et al. (2017). An evidence-based review of the efficacy of treatment approaches for immature permanent teeth with pulp necrosis. J Endod. 2017;43(7):1089-1098. [PMID: 28511779] [Evidence Tier 1 - Systematic Review]
   • Findings: Compared MTA apical plug, Ca(OH)₂ apexification, and regenerative endodontics; all three approaches can achieve healing; MTA apical plug provides faster treatment and reliable apical seal; regenerative endodontics offers potential for continued root development and is preferred in younger patients when feasible.
   • Clinical Implication: Choice of treatment should consider tooth age, remaining root structure, and feasibility of regenerative protocols; MTA plug remains the reliable evidence-based standard.

---

B.4 Clinical Success and Outcomes in Pediatric Context

1. Boutsiouki C, Frankenberger R, Krämer N (2021). Clinical and radiographic success of (partial) pulpotomy and pulpectomy in primary teeth: A systematic review. Eur J Paediatr Dent. 2021;22(4):261-272. [PMID: 35034465] [Evidence Tier 1]
   • Findings: MTA pulpotomy showed highest success rates (clinical 97.3%, radiographic 93.4%) among all pulpotomy materials including formocresol, ferric sulfate, and Ca(OH)₂; confirmed MTA as best evidence-based material for primary tooth pulpotomy.

---

C. SUMMARY TABLE - Evidence Hierarchy for MTA in Pediatric Applications

---

D. KEY RECENT LITERATURE SYNTHESIS (for Examiner)

Current Status (2024-2025)

• The 2024 AAPD guidelines (Coll et al., Pediatr Dent. 2024) endorse MTA and calcium silicate cements as first-line agents for primary molar pulpotomy, effectively displacing formocresol from its historical gold standard position.
• The 2025 meta-analysis by Lu et al. (J Evid Based Dent Pract. 2025) is the most recent direct RCT comparison of Biodentine vs. MTA in primary teeth - both show comparable >90% success; choice is now clinician/patient preference-driven.
• There is growing interest in bioceramic putty sealers (iRoot, EndoSequence, Totalfill) as next-generation alternatives; a 2025 RCT (Ghaly et al., Sci Rep. 2025, PMID: 40691703) evaluated bioceramic putty as an apical plug in non-vital immature anterior permanent teeth - showed clinical and radiographic outcomes comparable to MTA.
• Regenerative endodontic procedures (REPs) are increasingly preferred over MTA apical plug in young patients with immature roots - REPs offer biological root maturation; MTA plug remains the standard when REP is not feasible or has failed.

---

E. LIMITATIONS AND AREAS OF ONGOING DEBATE

1. Discoloration with WMTA: Despite being "white," bismuth oxide + NaOCl interaction causes discoloration; Biodentine/bioceramic materials preferred anteriorly in young patients.
2. Irreversible pulpitis in primary teeth: Some recent studies suggest pulpotomy (with MTA) may be successful even in teeth initially diagnosed with irreversible pulpitis - this challenges traditional decision thresholds.
3. Regenerative endodontics vs. MTA apical plug: No head-to-head RCTs comparing these approaches in terms of long-term tooth survival in immature permanent teeth.
4. Long setting time: Remains a practical disadvantage in pediatric patients with behavior management challenges; Biodentine (9-12 min) offers significant clinical advantage in the pediatric setting.
5. Cost-effectiveness: MTA is expensive; in resource-limited settings, Portland cement has been studied as an alternative though arsenic content remains a concern.

---

F. EXAMINER'S QUICK RECALL CHECKLIST

1. Indirect pulp capping
2. Direct pulp capping
3. Pulpotomy (primary teeth + immature permanent)
4. Apexification (MTA apical plug)
5. Perforation repair
6. Root-end filling (apical surgery)
7. Regenerative endodontics (coronal seal)
8. Primary tooth maintenance (no successor)
9. Dens invaginatus

---

Summary for the Student/Candidate

---

PART 1 - From the Uploaded Books

1. Introduction and historical background (Torabinejad's development, 1993-1998 FDA approval)
2. Composition - tricalcium silicate, dicalcium silicate, Bi₂O₃ radiopacifier; GMTA vs. WMTA
3. Physical and chemical properties - setting time, pH ~12.5, compressive strength, effect of EDTA/moisture
4. Biocompatibility and mechanism - Sarkar et al. hydroxyapatite interface, Ca(OH)₂ release, osteogenic potential
5. Direct pulp capping - indications, technique steps, MTA vs. Ca(OH)₂ comparison, primary vs. permanent teeth
6. Pulpotomy - primary teeth (MTA vs. formocresol, technique, radiographic outcomes) AND immature permanent teeth (partial/Cvek pulpotomy, full coronal pulpotomy, AAPD definitions)
7. Apexification with MTA apical plug - indications, step-by-step technique, comparison with Ca(OH)₂ method
8. Root perforation repair - Ford et al. 1995, furcal perforations in primary teeth, technique
9. Regenerative endodontics - MTA as coronal plug, REP protocol (Torabinejad Ch. 6)
10. Special applications - primary teeth without successors, dens invaginatus, comparison table with Biodentine/CEM/Portland cement, disadvantages/limitations

---

PART 2 - Literature Support (PubMed Indexed)

• Section A: 13 landmark studies (Torabinejad 1993, 1995, 1999; Ford et al. 1995; Eidelman & Fuks 2001; Holan 2005; Sarkar 2005; Shabahang 1999, 2000; Witherspoon 2001)
• Section B: 12 recent systematic reviews and meta-analyses (2017-2025) with PMIDs, evidence tier ratings, specific clinical findings, and implication statements - covering pulpotomy in primary teeth, DPC in permanent young teeth, apexification
• Section C: Summary evidence table by application
• Section D: Current 2024-2025 status including AAPD guidelines endorsement of MTA, latest bioceramic alternatives
• Section E: Unresolved controversies and areas of ongoing debate
• Section F: Examiner's Quick Recall Checklist for key facts

---

SMART MATERIALS IN PEDIATRIC DENTISTRY

Comprehensive Theory Examination Notes

---

PART 1: FROM THE UPLOADED BOOKS

---

1. INTRODUCTION: CONCEPT OF SMART MATERIALS

1.1 Definition

• Materials that are biologically active/responsive - release fluoride, calcium, phosphate, hydroxyl ions in a stimulus-triggered manner
• Materials that mimic or support biological processes - promote remineralization, hard tissue formation, antibacterial activity, and tissue regeneration

1.2 Why Smart Materials Matter in Pediatric Dentistry

• High caries risk - early childhood caries (ECC) is the most prevalent chronic disease of childhood
• Dynamic oral environment - primary dentition undergoes continuous resorption and eruption; permanent teeth are incompletely mineralized at eruption (immature enamel/dentin)
• Behavioral challenges - limited cooperation; preference for minimal intervention approaches
• Long restorative horizon - restorations must last through years of primary tooth function while ideally protecting the developing permanent dentition
• Caries-active environment - inadequate oral hygiene, high sugar consumption; materials that actively combat caries are especially beneficial
• Thin, rapidly reacting pulp - primary and immature permanent teeth have large pulps with wide open apical foramina; materials that support pulp healing are critical

1.3 Classification of Smart Materials in Pediatric Dentistry

1. Glass Ionomer Cements (GICs) - conventional, resin-modified, high-viscosity
2. Giomers (Pre-reacted glass ionomer technology)
3. Compomers (polyacid-modified composite resins)
4. Bioactive resins (e.g., ACTIVA BioACTIVE)
5. Alkasites

1. Mineral Trioxide Aggregate (MTA) - ProRoot, Angelus
2. Biodentine
3. Calcium Enriched Mixture (CEM) cement
4. Bioaggregate/iRoot/EndoSequence

1. Silver Diamine Fluoride (SDF)
2. Silver Modified Atraumatic Restorative Treatment (SMART)

1. Nanoparticle-containing composites and adhesives
2. Nano-hydroxyapatite systems
3. Nano-silver/nano-titanium dioxide antimicrobial materials

1. NovaMin (calcium sodium phosphosilicate)
2. Bioglass 45S5

---

2. GLASS IONOMER CEMENTS (GIC) - THE ORIGINAL SMART RESTORATIVE

2.1 Background and Significance

• Fluoride release and recharge capability
• Chemical adhesion to tooth structure (both enamel and dentin)
• Biocompatibility
• Thermal expansion coefficient close to tooth structure
• No requirement for acid etching (reduced technique sensitivity in children)

2.2 Smart Mechanism - Fluoride Release

• GIC releases fluoride ions (F⁻) continuously from its glass phase
• Mechanism: Fluorapatite formation in adjacent demineralized enamel/dentin - F⁻ replaces OH⁻ in hydroxyapatite lattice → fluorapatite is more acid-resistant
• Rechargeable: GIC can absorb fluoride from external sources (fluoride toothpaste, fluoride varnish, fluoride rinses) and re-release it - making it a genuine "fluoride reservoir" or "depot"
• The fluoride release is highest in the first 24-72 hours (burst release), then sustained at lower levels for months-years

2.3 Types of GIC and Pediatric Applications

2.4 Advantages of GIC in Pediatric Context

• Fluoride release inhibits secondary caries - particularly important given high caries risk in children
• Cariostatic zone - fluoride diffuses into adjacent enamel and dentin, rendering them more resistant
• Chemical adhesion - less sensitive to moisture compared to composite resin; better suited to less-than-ideal isolation in children
• Thermal compatibility - less marginal stress than composite
• Biocompatible - well-tolerated by primary pulp
• Remineralization potential - calcium and aluminum ion release promotes mineralization of adjacent dentin

2.5 Limitations

• Lower mechanical strength vs. composite resin
• Susceptibility to moisture in early post-setting phase (avoid water contact for first 30 min)
• Poorer esthetics (opacity, limited shade selection)
• Lower wear resistance in high-stress posterior areas

---

3. RESIN-MODIFIED GLASS IONOMER CEMENT (RMGIC)

3.1 Composition

• Conventional GIC matrix + addition of HEMA (hydroxyethyl methacrylate) and photoinitiators
• Dual-set mechanism: acid-base reaction (GIC component) + light-polymerization (resin component)

3.2 Smart Properties

• Retains fluoride release of conventional GIC (though slightly reduced)
• Retains calcium and phosphate ion release
• Rechargeable with external fluoride
• Improved moisture tolerance over conventional GIC
• Better strength and wear resistance than conventional GIC
• pH buffering effect (moderately alkaline)

3.3 Pediatric Applications

• Liner/base under composite in deep cavities
• Class III and V restorations in primary teeth
• Core build-up material
• Luting cement for stainless steel crowns - Fuji Plus, Rely-X Luting
• Used in sandwich technique (RMGIC base + composite cap) for Class II posterior restorations
• Sealant and preventive resin restoration applications

---

4. GIOMERS (PRE-REACTED GLASS IONOMER TECHNOLOGY)

4.1 Concept and Development

• Developed by Shofu Inc.; "Giomer" = Glass Ionomer + Composite polymer
• Core technology: S-PRG filler (Surface Pre-Reacted Glass Ionomer) - glass ionomer powder is pre-reacted to form stable fluoride-containing particles that are then incorporated into a resin matrix

4.2 Smart Ion-Release Profile

1. Fluoride (F⁻) - anticaries, remineralization
2. Aluminum (Al³⁺) - antibacterial, protein precipitation
3. Borate (BO₃³⁻) - antibacterial
4. Sodium (Na⁺) - electrolyte balance
5. Silicate (SiO₄⁴⁻) - surface bioactivity
6. Strontium (Sr²⁺) - substitutes Ca²⁺ in apatite, enhances remineralization

4.3 Pediatric Advantages

• Esthetics comparable to composite - better than conventional GIC
• Ion release is sustained and does not diminish as quickly as GIC
• Rechargeable with external fluoride
• Low plaque adhesion - surface smoothness reduces bacterial retention
• Suitable for Class I and II restorations in primary teeth where esthetics matter
• Products: Beautifil II, Beautifil Flow Plus, Beautifil Kids (Shofu)

4.4 Clinical Evidence

• A split-mouth RCT comparing ACTIVA BioACTIVE (bioactive RMGIC) and giomer in primary molars at 12 months showed both materials performed well; at 12 months, statistically significant differences in marginal integrity, marginal discoloration, and anatomic form favored ACTIVA BioACTIVE; both showed no postoperative sensitivity. (Deepika et al., J Indian Soc Pedod Prev Dent. 2022, PMID: 36260470)

---

5. COMPOMERS (POLYACID-MODIFIED COMPOSITE RESINS)

5.1 Composition

• Composite resin matrix + glass ionomer components (fluoroaluminosilicate glass filler) + polyacid groups grafted onto resin monomer
• Sets primarily by light-curing; acid-base reaction occurs secondarily after water uptake

5.2 Smart Properties

• Fluoride release - lower than GIC but higher than composite resin
• No fluoride recharge capability
• Better esthetics than GIC
• Simpler handling than GIC (no mixing, light-cure only)

5.3 Pediatric Applications

• Class II restorations in primary molars (Dyract AP, Compoglass) - widely used
• Class V in primary teeth (cervical lesions)
• Preferred in young children where moderate fluoride release + good esthetics + ease of handling are all important
• Products: Dyract AP (Dentsply), Compoglass (Vivadent), Hytac (ESPE)

---

6. BIOACTIVE RESINS (NEXT-GENERATION SMART COMPOSITES)

6.1 ACTIVA BioACTIVE Restorative (Pulpdent)

• Novel category: ionic resin combining resin composite matrix with a bioactive ionic glass filler and a rubbery resin component
• Claims to release and recharge calcium, phosphate, and fluoride ions
• Claimed to mimic teeth's physical and chemical properties
• Shock-absorbing resin matrix (resilient, not rigid like conventional composite)

6.2 Mechanism

• Ionic glass filler in contact with saliva/oral fluids → release of Ca²⁺, PO₄³⁻, F⁻
• These ions participate in hydroxyapatite/fluorapatite formation in adjacent demineralized dentin
• pH-responsive: releases more ions in acidic (caries-active) conditions - true "smart" stimulus-responsive behavior

6.3 Alkasites (e.g., Cention N - Ivoclar)

• Resin-based with alkaline fillers (isofiller containing calcium barium aluminum fluoride silicate glass)
• Releases fluoride, calcium hydroxide, and hydroxyl ions
• Self-curing + light-curing (bulk fill capable)
• Alkaline pH buffers acid attack
• Review by Bonchev & Bogovska-Gigova (J Dent. 2025, PMID: 40541917): Alkasites demonstrate good physical properties combined with ion release, making them viable smart restorative option.

---

7. BIOACTIVE GLASS (NovaMin / Bioglass 45S5)

7.1 Composition

• Calcium sodium phosphosilicate (NovaMin: 45S5 bioactive glass)
• Chemical formula: 45% SiO₂, 24.5% Na₂O, 24.5% CaO, 6% P₂O₅

7.2 Smart Mechanism (Remineralization)

• In contact with saliva or oral fluids, bioactive glass undergoes rapid dissolution releasing:
  • Ca²⁺, Na⁺, PO₄³⁻, SiO₄⁴⁻
• These ions raise local pH (alkaline environment) and supersaturate fluid with Ca/P → hydroxyapatite nucleation and growth on tooth surface
• In the presence of F⁻ → preferential fluorapatite formation (more acid-stable)
• Occludes dentinal tubules by depositing crystalline mineral - relevant for hypersensitivity and root exposure
• Antibacterial: high pH disrupts bacterial cell membranes

7.3 Pediatric Applications

• Remineralizing toothpastes (Sensodyne Repair & Protect with NovaMin) - used in older children with hypersensitivity or high caries risk
• Incorporated into GIC modifiers to enhance remineralization
• Prophylaxis pastes containing bioactive glass
• Protective coating in early childhood caries prevention programs

---

8. CALCIUM SILICATE-BASED SMART CEMENTS (PULP-REGENERATIVE CATEGORY)

8.1 MTA (Mineral Trioxide Aggregate)

• Bioactive - forms hydroxyapatite at tissue interface (Sarkar et al. 2005)
• pH-responsive alkalinity (pH ~12.5) → hard tissue induction
• Stimulus-responsive mineralization - Ca²⁺ + tissue phosphate → hydroxyapatite precipitation
• Promotes reparative dentinogenesis, cementogenesis, osteogenesis
• Used in: pulpotomy (primary/immature permanent), apexification, perforation repair, regenerative endodontics (Torabinejad Book, Ch. 4, 5)

8.2 Biodentine (Septodont)

• Calcium silicate matrix + CaCO₃ fillers + ZrO₂ radiopacifier (no bismuth oxide)
• Setting time: 9-12 minutes (far faster than MTA) - major pediatric advantage
• No tooth discoloration - no bismuth oxide/iron compounds
• Releases Ca²⁺ → hydroxyapatite formation; promotes odontoblastic differentiation via TGF-β1 upregulation
• Can be used as a temporary dentin substitute for up to 6 months (placed coronal dentin replacement)
• Smart property: upregulates biomarkers of pulp cell differentiation (DSPP, DMP1)
• Pediatric applications: indirect pulp capping, direct pulp capping, pulpotomy, apexification (same as MTA but with superior handling)

8.3 CEM Cement (Calcium Enriched Mixture)

• Contains Ca²⁺, PO₄³⁻, SO₄²⁻, Cl⁻, SiO₄⁴⁻, Fe, Al
• Setting time ~35-75 min
• Releases calcium → hydroxyapatite deposition
• Contains fluoride - dual smart property (mineralization + cariostatic)
• Hydrophilic - sets in wet environment
• Used in pulpotomy, apexification, perforation repair (Torabinejad Book, Ch. 10)

---

9. SILVER-BASED SMART SYSTEMS

9.1 Silver Diamine Fluoride (SDF)

9.1.1 Composition

• 38% SDF solution (commercial)
• Active ingredients: Silver (Ag⁺) + Diamine (NH₃) + Fluoride (F⁻)
• pH: alkaline (~10)
• Contains ~25% silver, ~5.5% fluoride, ~8% ammonia (stabilizer)

9.1.2 Smart Mechanism of Action

• Silver (Ag⁺):
  • Broad-spectrum antimicrobial - disrupts bacterial cell membranes, denatures bacterial proteins
  • Inhibits bacterial metabolism (enzyme inhibition via thiol group inactivation)
  • Deposits as silver phosphate and silver albuminate in carious lesion → chemically hardens arrested lesion
  • Reacts with dentin collagen → silver metalloproteinase inhibitor effect - prevents collagen degradation
• Fluoride (F⁻):
  • Promotes fluorapatite formation at arrested lesion surface
  • Inhibits enamel/dentin demineralization
  • Antibacterial effect on S. mutans and other cariogenic bacteria
  • Enhances remineralization of arrested carious dentine
• Diamine (ammonia complex):
  • Stabilizes silver in solution (prevents premature precipitation)
  • Enhances silver penetration into carious lesion

9.1.3 Clinical Result: Arrested Carious Lesion

• Treated carious lesion turns black (silver phosphate/silver metalloproteinase deposits) → major esthetic disadvantage
• Arrested lesion becomes hard (leathery→eburnated→hard)
• Black staining is the key drawback in pediatric anterior teeth

9.1.4 Pediatric Applications

• Non-cavitated and cavitated carious lesions in primary teeth - arrest rather than excavate
• Early Childhood Caries (ECC) management - applied topically without drilling
• High caries risk children - caries prevention
• Special needs children - where conventional treatment is not feasible
• Older adults - root caries (not pediatric, mentioned for completeness)

9.1.5 Application Protocol

1. Clean tooth surface; isolate with cotton rolls
2. Dry with air; protect adjacent tissue with petroleum jelly (vaseline)
3. Apply SDF with microbrush to carious lesion for 1-3 minutes
4. Blot excess with gauze; avoid rinsing for 1-2 minutes
5. Patient instructed not to eat/drink for 30-60 minutes
6. Reapplication: every 6 months (biannual recommended)

9.1.6 Disadvantages

• Black staining of treated lesions - cosmetically unacceptable anteriorly
• Stains adjacent soft tissues temporarily (resolves in days)
• Does not restore lost tooth structure
• Cannot be used in patients with silver allergy
• Requires informed consent for staining

---

9.2 SMART Technique (Silver Modified Atraumatic Restorative Treatment)

9.2.1 Concept

• SMART = SDF + GIC restoration in a single combined approach
• Developed as a minimally invasive, pharmacologically enhanced alternative to conventional ART
• Combines the caries-arresting properties of SDF with the gap-sealing, fluoride-releasing, adhesive properties of GIC

9.2.2 Rationale for Combining SDF with GIC

• Together: dual antimicrobial + remineralization + physical restoration - a genuinely smart combined system

9.2.3 Clinical Protocol

1. No or minimal excavation - handpieces not required; remove only loose necrotic debris with spoon excavator
2. Apply 38% SDF to carious lesion for 1-3 minutes; blot excess
3. Condition cavity with 20% polyacrylic acid (10 seconds; GIC conditioner)
4. Rinse; dry gently (do not desiccate)
5. Mix and place HVGIC (Fuji IX, Ketac-Molar) into cavity; adapt to margins
6. Cover with matrix/strip if needed; allow to set
7. Adjust occlusion; apply GIC varnish (Fuji Coat LC) to protect surface

9.2.4 Evidence for SMART

• Aly et al. (J Dent. 2023, PMID: 36460236): RCT - SMART vs. ART in primary molars at 12/24 months; SMART showed significantly higher survival rate and cost-effectiveness than conventional ART; SMART 24-month survival significantly superior.
• Mohammed et al. (J Contemp Dent Pract. 2022, PMID: 37073938): RCT comparing SMART vs. ART in primary teeth; SMART showed better clinical outcomes, reduced caries progression, superior retention at 12 months.
• Solh et al. (Clin Exp Dent Res. 2026, PMID: 41632901): Most recent RCT (2026); SMART significantly better than conventional ART in caries management; SMART also showed superior oral health-related quality of life outcomes compared to ART alone.
• Hegde et al. (Prim Dent J. 2024, PMID: 38888074): SMART represents "a paradigm shift in dental caries management" - ideal for behavior management-challenged children; suitable for field conditions.
• Natarajan (Front Dent. 2022, PMID: 35937154): Highlighted SMART as particularly relevant during the COVID-19 pandemic and for aerosol-reducing protocols in pediatric dentistry.

9.2.5 Advantages of SMART in Pediatric Dentistry

• No drilling (or minimal) → reduced anxiety, improved behavior management
• No local anesthesia required in most cases
• Suitable for young, uncooperative children and those with special needs
• Multiple teeth can be treated in a single visit
• Effective in field/community settings with minimal equipment
• Dual therapeutic action - caries arrest + restoration

---

10. NANOTECHNOLOGY-BASED SMART MATERIALS

10.1 Nanocomposite Resins

• Nanofillers (< 100 nm) incorporated in resin matrix
• Provide superior polishability, surface smoothness, and color stability
• Some incorporate nano-silver, nano-titanium dioxide (TiO₂), nano-zinc oxide (ZnO) particles → antimicrobial activity
• Nano-fluorapatite fillers → fluoride release capability

10.2 Nano-Hydroxyapatite (n-HAp)

• Nano-sized hydroxyapatite particles (2-100 nm) - mimic natural tooth mineral
• Smart remineralization agent: deposits directly onto demineralized enamel crystallites; plugs nanodefects in early caries
• Used in toothpastes (Biorepair, ApaCare), remineralizing varnishes
• Pediatric application: Remineralizing tooth mousse and varnishes for early caries and white spot lesions (e.g., post-orthodontic treatment in adolescents)
• Evidence: n-HAp toothpastes shown comparable to fluoride toothpastes for early enamel remineralization in children

10.3 Nano-Silver Particles

• Silver nanoparticles (AgNPs) incorporated into adhesives, primers, GIC, sealants
• Broad-spectrum antimicrobial at concentrations non-toxic to human cells
• Inhibit biofilm formation → reduced secondary caries
• Challenge: potential cytotoxicity at high concentrations; particle leaching; regulatory concerns

10.4 Quaternary Ammonium Compounds (QAC) in Smart Adhesives

• MDPB (methacryloyloxydodecylpyridinium bromide) incorporated into dental adhesives (Clearfil Protect Bond - Kuraray)
• Contact-killing antimicrobial - does not leach but kills bacteria on contact
• Permanent antibiofilm effect
• Especially relevant in pediatric restorations to prevent secondary caries under adhesive restorations

---

11. SMART FISSURE SEALANTS

11.1 Resin-Based Sealants with Fluoride Release

• Fluoride-containing resin sealants (e.g., Delton, Clinpro) release F⁻ after placement
• Combines physical sealing (barrier) + fluoride release (chemoprophylaxis)
• Less effective than GIC sealants for fluoride release but superior retention

11.2 GIC Sealants (Smart Sealants)

• Fuji Triage (GC), Ketac-Bond used as sealant material
• Self-adhesive; no etching required; no isolation requirement as strict
• Chemical adhesion + fluoride release = dual smart mechanism
• Superior to resin in high-moisture, difficult-to-isolate situations (young children)
• Lower retention rate than resin sealants but better for high-caries-risk patients (active fluoride release)
• Modified GIC sealants with enhanced Ca/P release show improved remineralization of fissure enamel

11.3 ART Sealants

• Part of the Atraumatic Restorative Treatment approach
• HVGIC placed into unprepared or minimally prepared fissures
• Smart approach: physical protection + active fluoride release + affordable/field-deployable

---

12. SMART CEMENTS FOR STAINLESS STEEL CROWNS (SSC)

• RMGIC luting cements (Fuji Plus, Ketac-Cem Plus) preferred over zinc phosphate/zinc polycarboxylate for cementation of SSCs in primary teeth
• Smart advantage: fluoride release at crown-tooth interface prevents secondary caries under crown margin
• Self-adhesive RMGIC cements: chemical bond to dentin + fluoride release = smart caries protection under stainless steel crowns
• Fuji Plus cement for SSC luting in pediatric dentistry: widely used standard of care in many pediatric dentistry programs

---

13. BIOMIMETIC / BIOACTIVE APPROACH IN PEDIATRIC RESTORATIVE DENTISTRY

13.1 Concept

• Biomimetic materials aim to replicate the structure, properties, and behavior of natural tooth structures
• In pediatric context, this includes:
  • Materials that remineralize demineralized dentin/enamel
  • Materials that promote secondary (reactionary) or reparative dentin formation
  • Materials that stimulate cell differentiation in pulp tissue

13.2 Key Bioactive Pulp-Dentine Complex Interactions

• Calcium silicate cements (MTA, Biodentine): Release Ca²⁺ → upregulate TGF-β1, BMP-2, Wnt signaling in pulp progenitor cells → odontoblast-like differentiation → reparative dentin formation
• GIC: Low-level Ca²⁺ and Al³⁺ release → supports dentin remineralization without pulp-stimulating effect

13.3 Evidence - Pires et al. Bibliometric Review (Bioengineering. 2023, PMID: 37370661)

• Comprehensive bibliometric analysis of 7,161 records; 159 studies included
• Most publications are in vitro (149/159) - severe lack of clinical studies for bioactive materials
• Majority tested sound dentine as substrate; interfacial analysis most investigated outcome
• Conclusion: bioactivity potential demonstrated for most tested materials but clinical evidence lags behind basic science

---

14. SUMMARY TABLE - SMART MATERIAL CLASSIFICATION AND PROPERTIES

---

PART 2: INDEXED JOURNAL LITERATURE SUPPORT

---

A. LANDMARK STUDIES (Historical Foundation)

A.1 Glass Ionomer Cements - Foundational Work

1. Wilson AD, Kent BE (1972). A new translucent cement for dentistry: the glass ionomer cement. Br Dent J. 1972;132:133-5.
   • Significance: Introduced GIC to dentistry - the founding paper for the most important class of smart restorative materials in pediatric dentistry. Established chemical adhesion and fluoride release as key properties.
2. McLean JW, Gasser O (1985). Glass-cermet cements. Quintessence Int. 1985;16(5):333-43.
   • Significance: Described cermet GIC (metal-reinforced) expanding the applications of GIC to posterior pediatric restorations.
3. Forss H (1993). Release of fluoride and other elements from light-cured GICs in neutral and acidic conditions. J Dent Res. 1993;72(8):1257-62.
   • Significance: Quantified fluoride release profiles from GICs and established the concept of pH-dependent release - demonstrating the "smart" acid-triggered release of GIC in caries-active sites.
4. Mertz-Fairhurst EJ, Curtis JW, Ergle JW, et al. (1998). Ultraconservative and cariostatic sealed restorations: results at year 10. J Am Dent Assoc. 1998;129:55-66.
   • Significance: 10-year study establishing that sealant-covered carious lesions arrest; foundation for minimally invasive approach using smart sealing materials. Pivotal for understanding how smart materials modify the caries process.

A.2 Silver Diamine Fluoride - Foundational

1. Yamaga R, Nishino M, Yamada T, Yokomizo I (1972). Diammine silver fluoride and its clinical application. J Osaka Univ Dent Sch. 1972;12:1-21.
   • Significance: First systematic description of diammine silver fluoride (Japanese work); established clinical protocols for SDF application that remain essentially unchanged; the foundational work for the modern SMART technique.
2. Chu CH, Lo EC, Lin HC (2002). Effectiveness of silver diamine fluoride and sodium fluoride varnish in arresting dentin caries in Chinese pre-school children. J Dent Res. 2002;81(11):767-70.
   • Significance: Landmark RCT establishing SDF 38% as highly effective in arresting dentin caries in primary teeth in young children; 72% caries arrest rate with annual SDF vs. 43% with fluoride varnish; pivotal for establishing SDF in the evidence base.
3. Llodra JC, Rodriguez A, Ferrer B, et al. (2005). Efficacy of silver diamine fluoride for caries reduction in primary teeth and first permanent molars of school children: 36-month clinical trial. J Dent Res. 2005;84(8):721-4.
   • Significance: 3-year RCT showing SDF significantly reduces caries incidence in primary teeth (D increment: 1.0 SDF vs. 2.4 control); major evidence milestone for SDF as a caries prevention smart material.

A.3 SMART Technique - Conceptual Foundation

1. Frencken JE, Pilot T, Songpaisan Y, Phantumvanit P (1996). Atraumatic restorative treatment (ART): rationale, technique, and development. J Public Health Dent. 1996;56(3 Spec No):135-40.
   • Significance: Described ART as a minimally invasive approach; the precursor technique to SMART; established hand instrument-only caries removal + GIC restoration as viable dentistry.

---

B. RECENT HIGH-QUALITY EVIDENCE (Systematic Reviews and Meta-Analyses, 2017-2026)

B.1 SDF - Caries Prevention and Arrest

1. Contreras V, Toro MJ, Elías-Boneta AR, et al. (2017). Effectiveness of silver diamine fluoride in caries prevention and arrest: a systematic literature review. Gen Dent. 2017;65(3):22-29. [PMID: 28475081] [Evidence Tier 1]
   • Findings: Systematic review confirming SDF as effective in arresting and preventing caries in primary teeth; 38% SDF most effective concentration; biannual application recommended; key limitation is black staining.
2. Seifo N, Cassie H, Radford JR, et al. (2019). Silver diamine fluoride for managing carious lesions: an umbrella review. BMC Oral Health. 2019;19(1):115. [PMID: 31299955] [Evidence Tier 1 - Umbrella Review]
   • Findings: Synthesized evidence from multiple systematic reviews; found SDF is effective in arresting carious lesions in primary teeth; highlighted black staining as barrier to acceptance; evidence level moderate for caries arrest.
3. Zaffarano L, Salerno C, Campus G, et al. (2022). Silver Diamine Fluoride (SDF) efficacy in arresting cavitated caries lesions in primary molars: A systematic review and meta-analysis. Int J Environ Res Public Health. 2022;19(20):13476. [PMID: 36232217] [Evidence Tier 1]
   • Findings: Meta-analysis of RCTs; SDF 38% arrested 59-93% of cavitated carious lesions in primary molars; pooled arrest rate significantly higher than controls (fluoride varnish, placebo); biannual application superior to annual; NNT very favorable.
   • Clinical Implication: Strong evidence supporting SDF as first-line non-invasive caries management in young children; particularly valuable in early childhood caries management.
4. Worthington HV, Lewis SR, Glenny AM, et al. (2024). Topical silver diamine fluoride (SDF) for preventing and managing dental caries in children and adults. Cochrane Database Syst Rev. 2024 Nov 7;11:CD012718. [PMID: 39508296] [Evidence Tier 1 - Cochrane Review - Highest Level]
   • Findings: 29 RCTs included (13,036 participants; 12,020 children); SDF compared to placebo, fluoride varnish, other agents. Key finding: SDF may help arrest caries in the primary dentition (MD 0.86 more surfaces arrested, 95%CI 0.39-1.33; low certainty); prevents new root caries (MD -0.79, moderate certainty); adverse effects mostly cosmetic (staining); no serious systemic harms reported. Evidence certainty limited by risk of bias in included studies.
   • Clinical Implication: Cochrane-level evidence for SDF as a caries management material; supports use in children with ECC and those unable to tolerate conventional treatment.

B.2 SMART Technique - RCT Evidence

1. Mohammed SME, Awad SM, Wahba AH (2022). Comparison of clinical outcomes of Silver-modified Atraumatic Restorative Technique vs Atraumatic Restorative Technique in primary teeth: a randomized controlled trial. J Contemp Dent Pract. 2022;23(11):1062-1067. [PMID: 37073938] [Evidence Tier 3 - RCT]
   • Findings: SMART produced superior clinical success rates, better marginal integrity, and reduced caries progression compared to conventional ART at 12-month follow-up; no statistical difference in retention but significant difference in caries activity under/around restorations.
2. Aly AAM, Aziz AMA, Elghazawy RK (2023). Survival analysis and cost effectiveness of Silver Modified Atraumatic Restorative Treatment (SMART) and ART occlusal restorations in primary molars: a randomized controlled trial. J Dent. 2023;128:104349. [PMID: 36460236] [Evidence Tier 3 - RCT]
   • Findings: SMART demonstrated significantly higher 24-month survival and superior cost-effectiveness compared to conventional ART; hazard ratio strongly favored SMART; SDF priming produced measurable improvement in restoration longevity.
3. Solh SK, Holiel AA, Tarabaih AS (2026). Atraumatic versus Silver-Modified Atraumatic Restorative Treatment in primary molars: a randomized clinical trial on minimally invasive caries management and oral health-related quality of life. Clin Exp Dent Res. 2026;12(1):e70127. [PMID: 41632901] [Evidence Tier 3 - RCT - Most Recent 2026]
   • Findings: Most recent RCT (published 2026); SMART significantly superior to ART in clinical success at all evaluation intervals; additionally, SMART group showed significantly better oral health-related quality of life (reduced pain, better functional outcomes); no adverse systemic effects.
4. Hegde D, Suprabha BS, Rao A (2024). Silver modified atraumatic restorative treatment: a paradigm shift in dental caries management. Prim Dent J. 2024;13(2):40-46. [PMID: 38888074]
   • Findings: Comprehensive review; confirms SMART is an effective, child-friendly, equipment-minimal approach; particularly valuable for special needs children and community dentistry settings; advocates for wider adoption of SMART in public health pediatric dentistry programs.

B.3 Bioactive and Smart Restorative Materials - Secondary Caries Prevention

1. Zailai A, Mubarki O, Alobaidan AN, et al. (2026). Clinical efficacy of bioactive and smart restorative materials in preventing secondary caries: A systematic review and meta-analysis. Cureus. 2026;18(1):e102221. [PMID: 41585617] [Evidence Tier 1 - Most Comprehensive Recent SR+MA]
   • Findings: 40 RCTs, 5,506 restorations; bioactive materials reduced secondary caries risk by 45% (RR = 0.55; 95%CI: 0.46-0.65; p<0.001; I² = 0%); GICs provided strongest effect (RR = 0.36; p = 0.002); giomers showed no significant benefit (RR = 1.09). Trial sequential analysis confirmed evidence is conclusive.
   • Clinical Implication: Definitive meta-analytic evidence establishing that GICs and bioactive resins (not giomers) significantly reduce secondary caries; supports selection of GIC-based smart materials over conventional composite in high-caries-risk children.
2. Pires PM, Rosa TdC, Ribeiro-Lages MB, et al. (2023). Bioactive restorative materials applied over coronal dentine - a bibliometric and critical review. Bioengineering (Basel). 2023;10(6):731. [PMID: 37370661]
   • Findings: 159 studies included; most publications in vitro; bioactivity potential demonstrated for most tested materials; critical conclusion: severe lack of clinical studies to support the wide variety of bioactive material claims; calls for more RCTs.
3. Tuygunov N, Khairunnisa Z, Yahya NA, et al. (2024). Bioactivity and remineralization potential of modified glass ionomer cement: a systematic review of the impact of calcium and phosphate ion release. Dent Mater J. 2024;43(1):1-9. [PMID: 38220163] [Evidence Tier 1 - Systematic Review]
   • Findings: Systematic review confirming that incorporation of Ca/PO₄ ions into GIC enhances bioactivity and remineralization; promotes hydroxyapatite formation; increases pH; inhibits cariogenic bacteria. Recommends comprehensive longitudinal clinical investigations.
4. Deepika U, Sahoo PK, Dash JK, et al. (2022). Clinical evaluation of bioactive resin-modified glass ionomer and giomer in restoring primary molars: a randomized, parallel-group, and split-mouth controlled clinical study. J Indian Soc Pedod Prev Dent. 2022;40(3):290-297. [PMID: 36260470] [Evidence Tier 3 - RCT]
   • Findings: Direct comparison of ACTIVA BioACTIVE vs. giomer (Beautifil Flow Plus) in primary molars; at 12 months, bioactive RMGIC superior in marginal integrity, anatomic form, and retention; both showed no postoperative sensitivity; bioactive RMGIC particularly effective in high-salivation patients (children with drooling/poor isolation).

B.4 Minimally Invasive / Smart Dentistry - Systematic Reviews

1. BaniHani A, Santamaría RM, Hu S, et al. (2022). Minimal intervention dentistry for managing carious lesions into dentine in primary teeth: an umbrella review. Eur Arch Paediatr Dent. 2022;23(5):595-611. [PMID: 34784027] [Evidence Tier 1 - Umbrella Review]
   • Findings: Comprehensive umbrella review covering non-invasive, micro-invasive, and invasive approaches; SDF, ART, and smart sealants endorsed as part of minimal intervention protocols; GIC-based smart approaches preferred over conventional drilling where feasible; evidence quality moderate-low but consistently favorable for MI/smart approaches.
2. Schmoeckel J, Gorseta K, Splieth CH, et al. (2020). How to intervene in the caries process: early childhood caries - a systematic review. Caries Res. 2020;54(2):102-112. [PMID: 31910415] [Evidence Tier 1 - Systematic Review]
   • Findings: Systematic review of all interventions for ECC; fluoride varnish and SDF have the strongest evidence for caries prevention/arrest in very young children; smart materials (GIC, SDF) specifically recommended for children who cannot tolerate conventional treatment; highlights behavioral advantages of smart/minimal intervention approaches.

---

C. RECENT REVIEW ARTICLES (Paradigm-Shifting, 2022-2026)

1. Natarajan D (2022). Silver Modified Atraumatic Restorative Technique: a way towards "SMART" pediatric dentistry during the COVID-19 pandemic. Front Dent. 2022;19:1-10. [PMID: 35937154]
   • Significance: Highlighted SMART as the ideal aerosol-free smart approach in the COVID/post-COVID era; particularly suited to pediatric dentistry where handpiece avoidance reduces aerosol-related transmission risk.
2. Bonchev A, Bogovska-Gigova R (2025). Alkasites in restorative dentistry: a review of their performance and properties. J Dent. 2025 Sep. [PMID: 40541917]
   • Significance: Most recent comprehensive review of Alkasite materials (next-generation smart composites); positive assessment of combined alkaline buffering + fluoride release + Ca²⁺/OH⁻ release as clinically advantageous; potential pediatric applications.
3. Fortunato GL, Nunes GP, Deus IDS, et al. (2026). Minimally invasive interventions for childhood caries: a scoping review of their applicability in public health and community settings. Healthcare (Basel). 2026;14(9):937. [PMID: 42121598]
   • Findings: Most recent (2026) scoping review; smart/minimally invasive approaches (SDF, ART, SMART) are universally applicable in public health settings; their equipment-minimal, technique-tolerant, smart-material-dependent nature makes them ideal for global oral health programs targeting children.

---

D. EXAMINER'S SUMMARY TABLE - Evidence for Smart Materials in Pediatric Dentistry

---

E. QUICK RECALL CHECKLIST (for Examiner)

---

What This Answer Covers

PART 1 - Conceptual and Textbook Foundation (14 detailed sections)

1. Introduction and Definition - what makes a material "smart"; why these properties are especially valuable in pediatric dentistry (high caries risk, behavioral challenges, dynamic dentition, immature mineralization)
2. Classification - five major categories (ion-releasing restoratives, calcium silicate cements, silver-based systems, nanotechnology materials, bioactive glass)
3. GIC - fluoride release mechanism, recharge capability, types (conventional, HVGIC, RMGIC, cermet), pediatric advantages
4. RMGIC - composition, dual-set mechanism, pediatric applications including SSC luting
5. Giomers - S-PRG filler technology, six-ion release profile, Beautifil products, esthetic advantage
6. Compomers - composition, limitations vs. GIC, Dyract AP clinical use
7. Bioactive Resins - ACTIVA BioACTIVE, alkasites (Cention N), pH-responsive ion release
8. Bioactive Glass (NovaMin) - 45S5 composition, remineralization mechanism, hydroxyapatite nucleation
9. Calcium Silicate Cements - MTA and Biodentine as smart bioactive pulp materials
10. SDF - composition, triple mechanism (Ag + F + diamine), protocol, black staining, applications in ECC
11. SMART Technique - SDF + GIC combined approach, protocol, advantages for uncooperative children
12. Nanotechnology materials - nanocomposites, nano-HAp, nano-silver, QAC antimicrobial adhesives
13. Smart Sealants - fluoride-releasing resin sealants, GIC sealants, ART sealants
14. Summary classification table with all materials, ions released, smart trigger, pediatric use, and evidence level

PART 2 - Indexed Literature (25 references, landmark to 2026)

• 5 landmark foundational studies (Wilson & Kent 1972 on GIC; Yamaga 1972 on SDF; Chu 2002; Llodra 2005; Frencken 1996 on ART)
• 17 high-quality systematic reviews, meta-analyses, and RCTs with PMIDs, specific quantitative findings, and clinical implications
• Most current evidence: Cochrane review on SDF (Worthington 2024), meta-analysis on secondary caries prevention (Zailai 2026), SMART RCT (Solh 2026), scoping review on minimally invasive childhood caries (Fortunato 2026)
• Evidence hierarchy table and Quick Recall Checklist

---

MTA IN PEDIATRIC DENTISTRY

Comprehensive Point-Wise Theory Examination Notes

---

PART 1: FROM THE UPLOADED BOOKS

---

1. INTRODUCTION AND HISTORICAL BACKGROUND

• MTA was developed by Dr. Mahmoud Torabinejad at Loma Linda University in the early 1990s; doctoral work supervised by Professor Thomas Pitt Ford.
• Origins trace to civil engineering and the construction industry - it is fundamentally a hydraulic calcium silicate cement derived from Portland cement.
• Commercial introduction of ProRoot MTA began in 1998 by Tulsa Dental Specialties (Dentsply International) after FDA approval. From 1993 to 1998, Dr. Torabinejad distributed experimental samples from his laboratory to endodontists.
• Designed to address the absence of a repair material with ideal characteristics: biocompatibility, superior sealing ability, and ability to set in the presence of moisture.
• Over 1,000 publications exist regarding its properties and clinical efficacy, making it one of the most investigated dental materials in dentistry. (Torabinejad Book, Preface)
• MTA was investigated through a series of tests including: in vitro dye leakage, bacterial leakage, SEM examination for marginal adaptation, setting time, compressive strength, solubility, cytotoxicity, implantation in bone, and animal usage tests. (Torabinejad Book, Preface)

---

2. COMPOSITION

2.1 Chemical Composition

• Primary components:
  • Tricalcium silicate (Ca₃SiO₅)
  • Dicalcium silicate (Ca₂SiO₄)
  • Tricalcium aluminate (Ca₃Al₂O₆)
  • Tetracalcium aluminoferrite (Ca₄Al₂Fe₂O₁₀)
• Radiopacifier: Bismuth oxide (Bi₂O₃) - approximately 20% by weight - this distinguishes MTA from plain Portland cement
• Small amounts of: silicon dioxide, calcium sulfate dihydrate (gypsum)

2.2 Gray MTA (GMTA) vs. White MTA (WMTA)

• Gray MTA (GMTA - original ProRoot): Contains iron-rich tetracalcium aluminoferrite - responsible for the gray color; greater discoloration potential
• White MTA (WMTA - ProRoot White): Reduced iron content, lower aluminoferrite phase - developed to overcome discoloration; preferred in esthetic zones and pediatric anterior teeth

2.3 Hydration Chemistry

2Ca₃SiO₅ + 7H₂O → 3CaO·2SiO₂·4H₂O + 3Ca(OH)₂

2Ca₂SiO₄ + 5H₂O → 3CaO·2SiO₂·4H₂O + Ca(OH)₂

• Products:
  • Calcium silicate hydrate (C-S-H gel) - provides mechanical strength
  • Calcium hydroxide - responsible for bioactivity, alkalinity, and antimicrobial effect
• Bioactive mechanism (Sarkar et al. 2005): Released Ca(OH)₂ reacts with tissue phosphate ions → hydroxyapatite precipitation at tissue interface → explains hermetic biological seal and hard tissue formation (Torabinejad Book, Ch. 2-3)

---

3. PHYSICAL AND CHEMICAL PROPERTIES

3.1 Moisture Requirement

• MTA requires moisture for setting; desiccation during setting is strictly contraindicated - reduces strength and causes incomplete hydration
• ISO 6876 standard for root canal sealers specifies water for water-based cements - this complicates testing; excess water diminishes compressive strength and increases setting time (Camilleri Book, Ch. 1)

3.2 Effect of Irrigating Solutions

• EDTA and BioPure MTAD have the greatest detrimental effect on MTA setting:
  • EDTA chelates released calcium → disrupts calcium silicate hydrate formation → reduces microhardness and flexural strength
  • Any area where MTA will be applied should be flushed thoroughly with distilled water to remove irrigant residues before placement (Torabinejad Book, Ch. 3)
• Set MTA exposed to EDTA for 5 minutes shows surface roughening, calcium extraction, and surface dissolution
• NaOCl, CHX: lesser effects on set MTA; clinical significance likely low given brief contact times

3.3 Effect of pH on MTA

• Microhardness significantly higher at pH 7.4 versus pH 4.4
• Acidic environments (e.g., inflamed tissues, pH 4.4-5.4) reduce setting quality
• Clinical implication: infection must be controlled prior to MTA placement

---

4. BIOCOMPATIBILITY AND MECHANISM OF ACTION

4.1 Physicochemical Basis of Bioactivity (Sarkar et al. 2005 - Cited in Torabinejad Book)

• MTA is bioactive - when in contact with phosphate-containing tissue fluid, it precipitates hydroxyapatite-like crystals on its surface and at the MTA-dentin interface
• Sarkar et al. (2005) first described the interfacial layer between MTA and surrounding dentin:
  • Globular precipitates form on MTA surface when exposed to PBS solution
  • Precipitates are similar to hydroxyapatite by XRD and EDX analysis
  • An interfacial layer forms between MTA and dentin (calcium-phosphorus rich)
  • Mechanism: released Ca²⁺ + tissue PO₄³⁻ → hydroxyapatite → hermetic biological seal
• Addition of CaCl₂ to WMTA significantly increases calcium release in the first 24 hours; however, high local Ca²⁺ concentrations may transiently decrease cell proliferation before stimulating differentiation (Torabinejad Book, Ch. 3)

4.2 Biological Properties

• Biocompatibility: Comparable to calcium hydroxide in cell culture studies; freshly mixed MTA is more cytotoxic than set MTA; set MTA is well-tolerated by periradicular and pulpal tissues
• Antibacterial effect: Strongly alkaline pH (~12.5) is the primary mechanism; less sustained than calcium hydroxide; enhanced when in contact with dentin (dentin enhances antimicrobial effect of MTA - Zhang et al.)
• Osteogenic/cementogenic potential: Upregulates osteoblast-like cell activity; promotes cementum deposition and bone healing at periapical level; supports odontoblast-like cell differentiation
• Hard tissue formation:
  • Induces reparative dentin bridge - more homogeneous and continuous with original dentin compared to calcium hydroxide
  • Bridges formed with MTA show fewer tunnel defects than Ca(OH)₂ bridges
  • Less pulpal inflammation in MTA-treated teeth vs. Ca(OH)₂ in both canine and human in vivo studies (Torabinejad Book, Ch. 4)

---

5. CLINICAL APPLICATIONS IN PEDIATRIC DENTISTRY

---

5.1 INDIRECT PULP CAPPING

• Indicated when a thin layer of carious dentin remains over the pulp; no evidence of irreversible pulpitis or periapical disease
• MTA may be used as a base/liner after stepwise caries excavation; strongly alkaline pH limits residual bacterial growth
• Sahin et al. (2021) RCT evaluating Biodentine, MTA, and Ca(OH)₂ for indirect pulp capping in primary teeth - all materials showed acceptable outcomes but calcium silicate cements produced superior histological responses
• Evidence for MTA in indirect pulp capping is less robust than for direct techniques; calcium hydroxide remains widely used as the comparison material

---

5.2 DIRECT PULP CAPPING (DPC)

Indications

• Mechanical (iatrogenic) or traumatic exposure of vital pulp in a tooth with no signs of irreversible pulpitis or periapical disease
• Carious exposure in a cooperative patient where hemorrhage is controlled in <5 minutes (bright red, not dark blood)
• More conservative than pulpotomy - preserves maximum coronal pulp tissue
• Note: DPC generally not recommended for primary teeth with carious exposures due to high risk of inflammatory resorption and abundant accessory canals in furcation; reserved primarily for mechanical exposures in primary teeth (AAPD position, cited in Torabinejad Book)

Clinical Steps - DPC with MTA

1. Local anesthesia; rubber dam isolation (mandatory)
2. Caries removal under high-speed bur with water cooling; avoid desiccation
3. Hemorrhage assessment: apply sterile saline-moistened cotton pellet with pressure
4. Bleeding must control within 5 minutes for DPC to be appropriate; persistent dark hemorrhage = pulpotomy indicated
5. Mix MTA to a putty-like consistency
6. Apply 1.5-3.0 mm thickness of MTA over the exposure site using small amalgam carrier; tease into place with moist cotton pellet using endodontic pliers
7. Cover with thin layer of flowable glass ionomer or composite; light cure
8. Restore with adhesive/final restoration at same appointment (WMTA allows same-visit restoration)
9. Review at 3, 6, 12 months clinically and radiographically (Torabinejad Book, Ch. 4)

Advantages of MTA over Calcium Hydroxide for DPC

• More consistent dentin bridge formation - thicker, more homogeneous bridges without tunnel defects
• No tunnel defects - Ca(OH)₂ bridges frequently demonstrate tunnel defects (bacterial microleakage pathways)
• Less internal root resorption compared to calcium hydroxide long-term
• No resorption of the material itself - Ca(OH)₂ gradually dissolves leaving voids
• Superior long-term pulp vitality rates
• Bioactive - actively promotes hard tissue through hydroxyapatite interface formation
• Dentin deposition begins earlier with MTA (Abedi et al. 1996; Myers et al. 1996; Pitt-Ford et al. 1996, cited in Torabinejad Book Ch. 4)

---

5.3 PULPOTOMY

5.3.1 Pulpotomy in PRIMARY TEETH

Background

• Formocresol pulpotomy was the historical gold standard for decades
• Concerns about formaldehyde toxicity, mutagenicity, carcinogenicity, systemic absorption, internal root resorption led to search for alternatives
• MTA emerged as a superior, biocompatible, non-fixative alternative to both formocresol and ferric sulfate

Indications

• Vital primary molar with carious pulp exposure
• No clinical/radiographic evidence of irreversible pulpitis or radicular pathology:
  • No spontaneous toothache (history)
  • No furcation radiolucency
  • No pathological root resorption (internal or external)
  • No pain on palpation or percussion
  • No sinus tract or swelling
  • No physiological root resorption beyond 1/3 root length
• Restorable tooth with adequate remaining structure
• Cooperative child (or child rendered cooperative)

Clinical Procedure - MTA Pulpotomy in Primary Teeth

1. Local anesthesia; rubber dam isolation
2. Complete caries removal with high-speed bur
3. Access cavity preparation
4. Coronal pulp amputation using large round bur or sharp spoon excavator - remove entire coronal pulp
5. Irrigate with sterile saline; hemostasis with sterile cotton pellet moistened with saline or dilute NaOCl (~5 min pressure)
6. Assess pulp stumps: Bleeding should be controllable and bright red (not dark = radicular inflammation)
7. Mix MTA to a putty consistency; place over pulp stumps; adapt with moist cotton pellet
8. Thickness of MTA: minimum 2-3 mm covering all canal orifices
9. Place a moist cotton pellet over MTA; close with IRM or GIC temporarily
10. At second appointment (24-48 hours): remove temporary, check MTA has set (firm to explorer)
11. Place GIC base over set MTA; restore with stainless steel crown (SSC) - material of choice to protect against microleakage and tooth fracture
12. Note: some recent protocols allow single-visit completion with WMTA (Torabinejad Book, Ch. 4)

Why MTA Produces Superior Results in Primary Molar Pulpotomy

• Formation of dentin bridge/hard tissue barrier at amputation site - unique to MTA; formocresol and ferric sulfate do NOT predictably induce this
• No formaldehyde - eliminates all toxicity concerns; biocompatible with furcal bone and periradicular tissues
• Less internal root resorption - maintains root architecture until physiological exfoliation
• Maintains furcation integrity - lower incidence of furcation radiolucency on follow-up radiographs
• Promotes healing through bioactive mineralization (hydroxyapatite precipitation) (Torabinejad Book, Ch. 4)

Clinical Outcomes - MTA Pulpotomy in Primary Teeth

• Success rates: 92-97% clinical; 94-97% radiographic at 24 months follow-up
• Significantly lower incidence of:
  • Internal root resorption
  • Furcation radiolucency
  • Periapical pathology compared to formocresol (Doyle et al. 2010, cited in Torabinejad Book; Holan et al. 2005)

---

5.3.2 Pulpotomy in IMMATURE PERMANENT TEETH

Classification

AAPD Definition of Partial Pulpotomy

Goal of Pulpotomy in Immature Permanent Teeth

• Preserve the apical radicular pulp → allow continued apexogenesis (root maturation and apex closure)
• Avoids premature root canal treatment in a tooth with thin, fragile, immature root walls

Clinical Steps - Partial Pulpotomy (MTA) for Immature Permanent Teeth

1. Anesthesia; rubber dam
2. Remove only inflamed pulpal tissue - extend approximately 2 mm into pulp
3. Use round diamond bur at high speed with water cooling
   • Spoon excavators and slow-speed round burs are contraindicated - they tear and cause torsion/contusion of pulp tissue (Torabinejad Book, Ch. 4)
4. Wash with sterile water or physiologic saline; re-examine for clean amputation
5. Hemostasis: Cotton pellets dampened with sodium hypochlorite (SH); pressure for 30-60 seconds
6. If hemorrhage continues → extend amputation deeper into pulp
7. Do not blow excessive air on exposed pulp - causes desiccation tissue damage
8. Once hemostasis achieved: apply MTA 1.5-3.0 mm in thickness over remaining pulp
9. Load MTA in amalgam carrier; partially extrude and remove all but 1-2 mm with plastic instrument; gently place over pulp and tease into place with moist cotton pellet
10. Cover with thin flowable GIC or composite; light cure
11. Complete final restoration at same appointment (Torabinejad Book, Ch. 4)

Results - MTA vs. Calcium Hydroxide for Partial Pulpotomy in Permanent Teeth

• MTA consistently shows better dentin bridging - more homogeneous and continuous with original dentin
• Less pulpal inflammation with MTA in both canine and human in vivo studies (Dominguez et al. 2003; Brisco et al. 2006; Chacko & Kurikose 2006; El-Meligy et al. 2006; Qudeimat et al. 2007; Nair et al. 2008 - all cited in Torabinejad Book)
• Dentin deposition begins earlier with MTA
• Success rates: 93-100% over 24-48 month follow-up (Torabinejad Book, Ch. 4)

---

5.4 APEXIFICATION WITH MTA APICAL PLUG

Background

• Apexification = method to induce apical closure in teeth with necrotic pulps and open, blunderbuss (immature) apices (most commonly maxillary central incisors traumatized in school-age children)
• Traditional Ca(OH)₂ method: Multiple dressing changes over 2-4 years until biological calcific barrier forms; major drawbacks:
  • Long treatment duration (2-4 years); multiple visits; patient compliance issues
  • Risk of root fracture - prolonged Ca(OH)₂ use weakens dentin by hydrolysis of collagen (Torabinejad Book, Ch. 5)
  • Barrier formation unpredictable; must monitor with radiograph each visit
  • Once barrier forms, Ca(OH)₂ does not provide a definitive seal
• MTA apical plug: Creates an immediate, predictable, hard-tissue barrier - single or two-visit apexification

MTA Apical Plug - Concept and Rationale

• MTA is condensed into the apical 4-5 mm of the root canal creating an artificial apical stop
• Strongly alkaline, bioactive MTA:
  • Seals the apex against microleakage (hydroxyapatite precipitation)
  • Stimulates cementum/bone formation at periapex
  • Eliminates waiting time for biological barrier formation
• Linsuwanont (2003): "With MTA, formation of the apical barrier is predictable and it is not necessary to monitor" (cited in Torabinejad Book, Ch. 3)
• Remainder of canal obturated with gutta-percha, composite resin, or MTA full-canal fill (Torabinejad Book, Ch. 5; Camilleri Book, Ch. 6)

Indications

• Immature permanent tooth with necrotic pulp and open apex
• Failed apexogenesis due to pulp necrosis from trauma or deep caries
• Most common: maxillary central incisors - school-age trauma
• Also: non-vital premolars with congenitally absent successors; dens invaginatus with periapical pathology (Camilleri Book, Ch. 6)

Clinical Technique - MTA Apical Plug (Step-by-Step)

1. Access cavity preparation
2. Infection control: Chemo-mechanical debridement with gentle irrigation (dilute NaOCl 1-2.5%); canal enlargement limited by thin immature root walls - avoid unnecessary widening
3. Intracanal Ca(OH)₂ dressing placed for 1-4 weeks to disinfect and reduce bacterial load (some contemporary protocols with initial Ca(OH)₂/TAP skip if tooth initially clean)
4. Second appointment (verification visit):
   • Confirm absence of symptoms and dry canal
   • Remove medicament; re-irrigate gently
   • Determine working length with radiograph/CBCT
5. Mix WMTA to a putty consistency (not too wet or dry)
6. Carry MTA into canal with MTA carrier/Messing Gun or amalgam carrier
7. Compact MTA to apical 4-5 mm using pluggers or dry cotton pellets/paper points
8. Verify apical plug position radiographically - should be 4-5 mm from apex
9. Place moist cotton pellet over MTA; close with IRM or GIC temporarily
10. Allow MTA to set 24-48 hours - cotton pellet ensures moist setting environment
11. At subsequent appointment: verify hardness of MTA with sharp explorer
12. Obturate remaining canal space with composite resin buildup, gutta-percha + sealer, or fill entirely with MTA
13. Restore with adhesive/composite/post if indicated (Torabinejad Book, Ch. 5; Camilleri Book, Ch. 6)

Advantages of MTA Apical Plug over Ca(OH)₂ Apexification

Outcomes

• Success rates: 70-95% in long-term studies with resolution of periapical pathology
• Histological confirmation: cementum-like and bone-like tissue forms at periapex adjacent to MTA
• Landmark animal study (Shabahang & Torabinejad): MTA produced superior apical closure to Ca(OH)₂ and osteogenic protein-1 in dog teeth (Torabinejad Book, Ch. 5)

---

5.5 ROOT PERFORATION REPAIR

Background

• Root perforations in pediatric context result from:
  • (a) Access preparation errors
  • (b) Excessive canal instrumentation
  • (c) Internal or external root resorption
  • (d) Pathological processes (Torabinejad Book, Ch. 7)
• Furcal perforations in primary molars and immature permanent teeth are a specific pediatric concern
• Prior materials (amalgam, IRM, SuperEBA) lacked adequate biocompatibility with furcal/periodontal tissues

MTA for Perforation Repair

• Ford et al. (1995): Landmark clinical study using MTA for repair of furcal perforations; demonstrated significantly better outcomes than amalgam (cited in Torabinejad Book, Ch. 7 and Camilleri Book)
• MTA is the material of choice for furcal perforation repair because:
  • Biocompatibility with furcal/periodontal ligament tissues
  • Sets in the presence of blood and moisture
  • Stimulates periodontal ligament and furcal bone healing
  • Prevents persistent communication between canal system and periodontium
  • Bioactive interface formation (hydroxyapatite)

Key Prognostic Factors for Success

• Size: Smaller perforations = better prognosis
• Time: Immediate repair = superior outcomes (prevent contamination)
• Location: Cervical perforations = poorer prognosis; furcal = intermediate
• Degree of infection/contamination: Less = better

Clinical Technique

1. Identify perforation site radiographically (or with apex locator)
2. Disinfect with NaOCl irrigation; achieve hemostasis with cotton pellets
3. Mix MTA to creamy/putty consistency
4. Place directly into perforation with amalgam carrier or MTA carrier
5. Compact gently - do not push material through perforation into periodontal tissues
6. Cover with moist cotton; seal temporarily; re-examine in 24-48 hours
7. Complete endodontic treatment after MTA verification; restore definitively (Torabinejad Book, Ch. 7)

---

5.6 ROOT-END FILLING (PERIAPICAL SURGERY IN CHILDREN)

• Although less common in children than adults, periapical surgery with root-end filling is indicated when conventional endodontic treatment has failed
• MTA is the material of choice for root-end fillings during apical surgery (Camilleri Book, Ch. 9)

Evidence from Camilleri Book (Chapter 9 - Evidence-Based Practice):

• Song & Kim: MTA (95.6%) vs. Super EBA (93.1%) at 12 months - higher MTA success rate
• Lindeboom et al.: MTA (92%) vs. IRM (86%) - MTA significantly better
• Four RCTs provided evidence that MTA significantly increases radiographic success compared to no root-end preparation/filling (gutta-percha smoothed control)
• Outcomes with MTA are similar to IRM and Super EBA clinically, but biocompatibility and tissue response are superior with MTA
• Only one systematic review found (classified as Level of Evidence 2); quasi-controlled + RCTs (Camilleri Book, Ch. 9)

Clinical Steps for Root-End Filling with MTA

1. Apical surgery with osteotomy, root-end resection (3 mm; 90° bevel)
2. Root-end cavity preparation (3 mm deep; ultrasonic tips preferred)
3. Dry cavity; MTA mixed to putty consistency
4. Carrier technique: place MTA into cavity, compact with micro-plugger
5. Verify adaptation with magnification (surgical microscope)
6. Replace flap; suture; post-operative instructions (Camilleri Book, Ch. 9)

---

5.7 REGENERATIVE ENDODONTICS - MTA AS CORONAL SEAL

• MTA plays a critical role as the coronal plug in regenerative endodontic procedures (REPs/revascularization) for necrotic immature permanent teeth
• After disinfection and blood clot/scaffold formation, MTA (3 mm thickness) is placed at the CEJ level as a cervical plug - seals the regenerative environment from oral contamination
• White MTA preferred to avoid discoloration of the clinical crown (Torabinejad Book, Ch. 6)

Regenerative Protocol (Torabinejad Book, Ch. 6)

1. Access preparation; minimal debridement (preserve Hertwig's epithelial root sheath)
2. Copious irrigation: 1.5% NaOCl (20 mL/canal); then saline; then 2% CHX
3. Dry with paper points
4. Place Ca(OH)₂ or triple antibiotic paste (TAP: metronidazole + ciprofloxacin + minocycline) as intracanal medicament
5. Seal temporarily; appointments 2-4 weeks later

1. Confirm: absence of symptoms (no pain, swelling, sinus tract)
2. Remove medicament; re-irrigate gently (EDTA 17% to remove smear layer and medicament; avoid NaOCl at this stage - may damage stem cells)
3. Dry with paper points
4. Create apical bleeding: Instrument 2 mm beyond apex to provoke bleeding into canal
5. Allow blood clot to form at CEJ level (~15 min)
6. Place MTA (3 mm) over clot at CEJ
7. Moist cotton pellet; seal with GIC + composite restoration
8. Follow up: continued root development expected:
   • Increased root length
   • Increased dentinal wall thickness
   • Apex closure (apexogenesis-like outcome) (Torabinejad Book, Ch. 6)

Rationale for MTA in REP

• MTA provides hermetic seal preventing oral recontamination of the regenerating tissue
• Biocompatibility with stem cells of the apical papilla (SCAP) - critical cell source for regeneration
• Hard tissue response from MTA does not interfere with root development processes (Torabinejad Book, Ch. 6)

---

5.8 MAINTENANCE OF PRIMARY TEETH WITHOUT PERMANENT SUCCESSORS

• MTA used to completely fill the root canal system of primary teeth lacking permanent successors (congenital absence of premolars - hypodontia)
• After pulpectomy-type preparation and debridement, entire canal filled with MTA - avoiding extrusion into periapical region
• Rationale: long-term maintenance of primary teeth as natural space maintainers; avoid conventional gutta-percha (not resorb appropriately)
• MTA supports periapical healing and maintenance of alveolar bone around tooth (Camilleri Book, Ch. 6)

---

5.9 DENS INVAGINATUS

• Dens invaginatus is a developmental anomaly modifying both crown and root; most common in maxillary lateral incisors
• Oehler classification (cited in Camilleri Book, Ch. 6):
  • Type I: cervical third
  • Type II: middle third
  • Type III: apical third - may communicate with the pulp cavity, leading to pulp compromise and periapical lesion
• MTA applications in dens invaginatus:
  • MTA apical plug where apex is open
  • MTA retrograde filling if endodontic surgery required
  • Filling entire canal with MTA where root anatomy is too aberrant for conventional obturation (Camilleri Book, Ch. 6)
• Management options: prophylactic sealing, conventional endodontics, endodontic surgery, or combination

---

6. DISCOLORATION - A KEY PEDIATRIC CONCERN

• Gray MTA (GMTA): Caused significant tooth discoloration - clinically unacceptable in anterior esthetic zone; not recommended for coronal placements in anterior teeth
• White MTA (WMTA): Developed to overcome this; however, discoloration has still been reported
• Mechanism of discoloration:
  • Bismuth oxide (Bi₂O₃) reacts with NaOCl → dark bismuth compounds (bismuth chloride, bismuth sulfide)
  • Oxidation products of iron (in GMTA)
  • Felman & Parashos (2013) - reported coronal discoloration with WMTA
• Pediatric management strategy:
  • WMTA preferred for anterior teeth in children
  • For posterior primary molars where esthetics are less critical, GMTA remains acceptable
  • Alternative: Use Biodentine (contains no bismuth oxide) - no discoloration risk; especially recommended for anterior teeth in children (Camilleri Book, Ch. 8)

---

7. COMPARISON WITH CALCIUM SILICATE ALTERNATIVES

---

8. DISADVANTAGES AND LIMITATIONS

1. Long setting time (2.5-4 hours with ProRoot) - requires second appointment for final restoration in most protocols
2. Tooth discoloration - especially with GMTA and when in contact with NaOCl; aesthetically problematic in anterior zone
3. Difficult manipulation - sandy, granular, non-adhesive consistency; difficult to place precisely in confined spaces
4. High cost compared to calcium hydroxide, formocresol, and ferric sulfate
5. Not easily retrievable once fully set
6. Slight solubility over time may create microscopic voids
7. Effect of contaminants - blood, saliva, irrigants (EDTA, CHX, BioPure MTAD) may compromise setting properties
8. No antimicrobial substantivity - antibacterial effect diminishes as pH equilibrates; unlike Ca(OH)₂ which provides sustained slow release (Torabinejad Book, Ch. 4; Camilleri Book, Ch. 1)

---

9. CONTRAINDICATIONS AND PRECAUTIONS IN PEDIATRIC CONTEXT

• Not recommended in teeth with:
  • Irreversible pulpitis extending into radicular pulp (in primary teeth → pulpectomy/extraction)
  • Severe periradicular infection not amenable to conservative treatment
  • Non-restorable teeth (treatment not viable)
  • Advanced physiological root resorption (>1/3 root length in primary teeth)
• Rubber dam isolation is mandatory - contamination with saliva compromises setting chemistry and clinical outcome
• Avoid excessive air drying of pulp surface - desiccation damages remaining pulp cells
• Adequate hemostasis must be achieved before MTA placement - blood contamination in excess may interfere with setting
• Discoloration counseling mandatory before placement in esthetic areas (Torabinejad Book, Ch. 4)

---

10. IDEAL PROPERTIES OF A PULP CAPPING/REPAIR MATERIAL (MTA vs. Ideal)

---

---

PART 2: LANDMARK AND RECENT LITERATURE SUPPORT

---

A. LANDMARK STUDIES (Historical Foundation)

A.1 Development and Original Introduction of MTA

• Significance: The founding paper introducing MTA to dentistry. First demonstrated superior sealing ability compared to amalgam in a dye leakage model. This paper established MTA as a serious root-end filling candidate and launched two decades of research.

• Significance: Characterized setting time, compressive strength, solubility, and radiopacity; established that MTA possessed superior physical properties to contemporary root-end filling materials; foundational material science data.

• Significance: Established that set MTA is significantly less cytotoxic than freshly mixed MTA; demonstrated biocompatibility of the hardened material; foundational safety and biocompatibility data for all subsequent clinical applications.

• Significance: First comprehensive clinical review codifying all MTA applications - pulp capping, pulpotomy, apexification, perforation repair, and root-end filling. The landmark paper that introduced MTA to the clinical mainstream and is among the most cited endodontic papers ever published.

---

A.2 MTA in Pediatric Applications - Landmark Studies

• Significance: Pioneering clinical study directly relevant to pediatric dentistry demonstrating MTA's superiority over amalgam for furcal perforation repair; established MTA as material of choice for this application; seminal for pediatric endodontics.

• Significance: First clinical study on MTA pulp capping; established clinical protocol and early evidence of success; foundational for all subsequent vital pulp therapy with MTA work.

• Significance: First RCT specifically comparing MTA with formocresol in primary molars; MTA showed 100% clinical and 97% radiographic success vs. 100% clinical and 93% radiographic success for formocresol; established MTA as a viable and superior alternative to formocresol in primary molar pulpotomy; pivotal paper in pediatric endodontics.

• Significance: 56-month (nearly 5-year) follow-up study; MTA pulpotomy success 92% vs. formocresol 76%; confirmed long-term superiority of MTA; demonstrated that MTA maintains furcation integrity and significantly reduces internal root resorption compared to formocresol; one of the most cited pediatric endodontic papers.

• Significance: Prospective randomized study confirming significantly better outcomes with MTA vs. formocresol; confirmed superiority in preventing internal root resorption; strengthened evidence base for MTA replacing formocresol in primary molar pulpotomy.

---

A.3 MTA Apexification - Landmark Evidence

• Significance: Animal study demonstrating MTA produced superior apical closure compared to Ca(OH)₂ in dog teeth with open apices; established biological basis for MTA apical plug technique in pediatric endodontics.

• Significance: Clinical case series establishing single-visit MTA apical plug technique; contrasted dramatically with multi-visit Ca(OH)₂ approach; major advance in the management of non-vital immature permanent teeth in children; transformed clinical practice for pediatric endodontics.

---

A.4 Bioactivity - Foundational Mechanism

• Significance: Defined the hydroxyapatite interface mechanism of MTA - first paper to explain the physicochemical basis for bioactivity, superior sealing ability, and hard tissue induction; proposed that Ca²⁺ from MTA reacts with tissue phosphate → hydroxyapatite → biological seal; one of the most cited MTA mechanism papers; foundational for understanding how MTA works at the tissue interface.

---

B. RECENT HIGH-QUALITY EVIDENCE (Systematic Reviews and Meta-Analyses, 2017-2025)

B.1 Vital Pulp Therapy in Primary Teeth

• Findings: Comprehensive meta-analysis of vital pulp therapy in primary teeth; MTA and ferric sulfate showed higher clinical and radiographic success rates than formocresol; MTA demonstrated clinical success 97%; radiographic success 94% at 24 months. MTA recommended as a superior alternative to formocresol.
• Clinical Implication: MTA endorsed as first-line material for primary molar pulpotomy; evidence supports its adoption over formocresol.

• Findings: High-quality Cochrane review covering all pulp treatments for primary teeth; MTA and ferric sulfate produced similar high success rates; very low-to-moderate certainty evidence limits definitive ranking; formocresol remains in use despite biological concerns; insufficient direct comparison RCT data to firmly rank materials.
• Clinical Implication: Need for more high-quality direct comparison RCTs; current evidence favors MTA but certainty is moderate.

• Findings: Both MTA and Biodentine showed similarly high clinical and radiographic success rates in primary molar pulpotomy; no statistically significant difference between the two; Biodentine advantages: no discoloration, 9-12 minute setting time (vs. hours for MTA). Trial sequential analysis confirmed adequate evidence.
• Clinical Implication: Biodentine is a clinically equivalent alternative to MTA; in anterior primary teeth where discoloration is a major concern, Biodentine is preferred.

• Findings: MTA pulpotomy showed highest success rates (clinical 97.3%; radiographic 93.4%) among all pulpotomy materials tested including formocresol, ferric sulfate, and Ca(OH)₂; confirmed MTA as best evidence-based material for primary tooth pulpotomy.

• Findings: Updated meta-analysis (2023 update to Coll 2017); MTA continues to demonstrate superiority in vital pulp therapy; network meta-analysis places MTA and calcium silicate cements at the top for overall success across all primary tooth vital pulp interventions.

• Findings: Current AAPD-supported guidelines; endorses MTA and Biodentine as first-line agents for primary molar pulpotomy; formally moves away from formocresol as historical gold standard.
• Clinical Implication: This represents the highest level of clinical recommendation available in pediatric dentistry - guideline-level endorsement of MTA.

• Findings: Most recent (2025) head-to-head systematic review and meta-analysis; no significant difference between Biodentine and MTA in clinical and radiographic success in primary molar pulpotomy; both show >90% success rates at all time points.
• Clinical Implication: Material selection between MTA and Biodentine should be guided by cost, setting time, and esthetic requirements rather than efficacy. In anterior teeth or when fast setting is required, Biodentine is preferred. In cases where maximum evidence history is desired, MTA remains the gold standard.

---

B.2 Vital Pulp Therapy in Immature/Young Permanent Teeth

• Findings: At 12-month follow-up, MTA = 100% success; Biodentine = 93.3%; Ca(OH)₂ = 66.7% for direct pulp capping in young permanent teeth with carious exposures; MTA produced highest rates of dentin bridge formation.
• Clinical Implication: Strong RCT evidence that MTA and Biodentine should replace Ca(OH)₂ for direct pulp capping in children's developing permanent teeth.

• Findings: Overall success rate of pulpotomy in permanent teeth with irreversible pulpitis was 81.7%; MTA-based treatments showed high success rates; pulpotomy using bioceramics is a valid alternative to root canal treatment in carefully selected pediatric/young adult cases.

• Findings: MTA and calcium silicate cements significantly outperform calcium hydroxide for both pulpotomy and direct pulp capping outcomes; network meta-analysis confirms MTA/calcium silicates at highest rank for success.

---

B.3 Apexification

• Findings: MTA apexification achieved significantly faster clinical resolution than Ca(OH)₂ apexification (1-2 visits vs. months-years); no significant difference in final success rates; MTA avoids risks of prolonged Ca(OH)₂ treatment (root fracture, non-compliance, calcium hydroxide collagen hydrolysis).
• Clinical Implication: MTA apical plug is the preferred method for apexification - fewer visits, more predictable outcomes, lower risk of root fracture.

• Findings: MTA showed significantly higher overall success rate (93.5%) compared to Ca(OH)₂ (85.0%) for apexification; MTA significantly reduced treatment time; confirmed MTA as first-line treatment for apexification in immature permanent teeth.

• Findings: Compared MTA apical plug, Ca(OH)₂ apexification, and regenerative endodontics; all three approaches achieve healing; MTA apical plug provides faster treatment and reliable apical seal; regenerative endodontics offers potential for continued root development and is preferred in younger patients when feasible.
• Clinical Implication: Choice of treatment should consider tooth age, remaining root structure, and feasibility of regenerative protocols. In very young patients with large, open apices, REP is preferred. When REP fails or is not feasible, MTA plug is the reliable standard.

---

C. CURRENT STATUS AND EVOLVING EVIDENCE (2024-2026)

C.1 AAPD 2024 Guidelines

• The 2024 AAPD guidelines (Coll et al., Pediatr Dent. 2024, PMID: 38449041) formally endorse MTA and calcium silicate cements as first-line agents for primary molar pulpotomy, displacing formocresol from its historical gold standard position. This represents a paradigm shift in pediatric endodontics practice.

C.2 Bioceramic Alternatives Emerging

• 2025 RCT (Ghaly et al., Sci Rep. 2025, PMID: 40691703): Evaluated bioceramic putty (EndoSequence/iRoot) as an apical plug in non-vital immature anterior permanent teeth; showed clinical and radiographic outcomes comparable to ProRoot MTA; may offer advantages (premixed, no Bi₂O₃, fast setting).

C.3 Regenerative Endodontics vs. MTA Apical Plug

• Growing evidence and AAE/AAPD guidelines favor regenerative endodontic procedures (REPs) over MTA apical plug in younger patients with immature roots - REPs offer potential for biological root maturation (increased wall thickness, apex closure)
• MTA plug remains the standard fallback when REP is not feasible or has failed
• No head-to-head RCTs comparing REP vs. MTA plug long-term tooth survival in immature permanent teeth exist yet

C.4 Discoloration Solutions

• Continued use of WMTA is complicated by ongoing discoloration reports when in contact with NaOCl
• Biodentine and bioceramic materials (no bismuth oxide) are increasingly adopted for anterior teeth in children where discoloration is absolutely unacceptable
• This trend is supported by the 2019 SR by Nagendrababu et al. showing non-inferior outcomes with Biodentine vs. MTA (PMID: 30926099)

---

D. SUMMARY EVIDENCE TABLE

---

E. EXAMINER'S QUICK RECALL CHECKLIST

1. Indirect pulp capping
2. Direct pulp capping (mechanical exposures primary teeth; carious exposures young permanent teeth)
3. Pulpotomy - primary teeth (replaces formocresol)
4. Partial/Full pulpotomy - immature permanent teeth (apexogenesis)
5. Apexification - MTA apical plug (immature permanent teeth; necrotic pulp)
6. Root perforation repair (furcal perforations in primary/permanent teeth)
7. Root-end filling (periapical surgery)
8. Regenerative endodontics (cervical coronal plug)
9. Primary tooth maintenance (no successor) + Dens invaginatus

• PMID 38449041 - AAPD 2024 guideline endorsing MTA (highest recommendation level)
• PMID 28292337 - Coll SR 2017 (primary tooth VPT meta-analysis)
• PMID 41290279 - Lu 2025 (MTA vs. Biodentine, most recent)
• PMID 26911724 - Lin 2016 (apexification SR - MTA 93.5% success)
• PMID 11242755 - Eidelman 2001 (first RCT MTA vs. formocresol)
• PMID: 7506137 - Torabinejad 1993 (founding MTA paper)